Medication Nonadherence Among African American Male Psychiatric Patients: Healthcare Providers’ Perspectives by Agoye, Felix O
Walden University 
ScholarWorks 
Walden Dissertations and Doctoral Studies Walden Dissertations and Doctoral Studies Collection 
2020 
Medication Nonadherence Among African American Male 
Psychiatric Patients: Healthcare Providers’ Perspectives 
Felix O. Agoye 
Walden University 
Follow this and additional works at: https://scholarworks.waldenu.edu/dissertations 
 Part of the Medicine and Health Sciences Commons 
This Dissertation is brought to you for free and open access by the Walden Dissertations and Doctoral Studies 
Collection at ScholarWorks. It has been accepted for inclusion in Walden Dissertations and Doctoral Studies by an 



















This is to certify that the doctoral dissertation by 
 
 
Felix O. Agoye 
 
has been found to be complete and satisfactory in all respects,  
and that any and all revisions required by  




Dr. Gudeta Fufaa, Committee Chairperson, Health Services Faculty 
Dr. Egondu Onyejekwe, Committee Member, Health Services Faculty 






Chief Academic Officer and Provost 









Medication Nonadherence Among African American Male Psychiatric Patients:  
Healthcare Providers’ Perspectives 
 
by 
Felix O. Agoye 
MPH, Walden University, 2013 
BA/BS, Chicago State University, 2010 
 
Dissertation Proposal Submitted in Partial Fulfillment 
of the Requirements for the Degree of 





African American men show less adherence toward maintenance pharmacotherapy for 
psychiatric disorders than Caucasian men. However, studies that specifically investigated 
the sociodemographic determinants of medication nonadherence in African American 
psychiatric patients based on healthcare providers’ perspectives are limited. Therefore, 
this study explored the viewpoints of healthcare workers in a Chicago-area hospital 
network about medication nonadherence among psychiatric African American male 
patients. This qualitative case-study is guided by the health-communication model and 
theory of planned behavior. Interview sessions were conducted with providers who met 
the inclusion criteria and NVivo 11  was used to store and organize the data in order to 
answer the research questions. Of the 40 participants, 55% mentioned that older U.S. 
male psychiatric patients are more nonadherent. Furthermore, 80% of participants noted 
that the presence of a significant partner serving as an emotional-support system induces 
patients to avoid medication nonadherence. Study findings revealed that it is important 
for providers to especially cater to African America patients, due to inherent risk factors. 
Although African American male psychiatric patients may be culturally challenged by 
medication nonadherence, the ability to manage their condition, recover fully, and lead 
normal lives is possible. This study promotes social change by offering focused practices 
for training and retraining of healthcare workers who provide care to African American 
male psychiatric patients. Study results represent a potential impact for positive social 
change by providing evidence that improving providers’ perceptions of patients is an 
additional approach to improving overall patient care. 
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Chapter 1: Introduction to the Study 
This study explored how healthcare providers (HCPs) perceive demographic and 
socioeconomic factors and characteristics that influence medication nonadherence among 
African American male psychiatric patients. Medication nonadherence is a pressing 
problem in healthcare in general and involves the treatment of psychiatric patients in 
particular. Therefore, studies like this are important to ensuring overall health outcomes 
involving African Americans. In a 2005 study involving patients in the United States, the 
category of patients with recurring psychiatric disorders such as depression and 
schizophrenia, 70% demonstrated noncompliance and nonadherence toward their 
medications (Baldessarini, Henk, Sklar, Chang, & Leahy, 2005). The inability of patients 
with psychiatric disorders to be compliant with medications can create adverse 
implications for their health and personal well-being as well as poor health outcomes 
(Lepage, Bodnar, Joober, & Malla, 2010). 
Poor adherence to a medication regimen has important implications for therapy 
effectiveness and an overall improvement in the positive health outcomes of patients. 
Bazargan et al. (2017) said that 20 to 30% of prescribed medications are not filled by 
African American psychiatric patients. Furthermore, 50% of the medications that are 
filled are not taken as prescribed by the provider. Medication nonadherence is common 
among psychiatric patients and involves not filling or refilling prescriptions, medication 
duplication, taking the wrong dosage or amount, missing days, poor timing, or not taking 
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medication according to the physicians’ orders (Lacro, Dunn, Dolder, Leckband, & Jeste, 
2002). 
Moreover, nonadherence can affect employment status, quality of relationships, 
income capacity, and sense of social responsibility (McGuire & Miranda, 2008). 
Medication nonadherence among African American male psychiatric patients is 
disproportionately higher than in other populations (Braverman & Dedier, 2009). The 
nonadherence rate of African American male psychiatric patients’ in the United States 
stands at 41%, compared to 21% among Caucasian psychiatric patients (McKirnan & 
Jones, 2014). These statistics suggest the crucial importance of examining determinants 
of medication nonadherence in psychiatric populations such as African American male 
patients. 
In addition, understanding HCPs’ perspectives and attitudes is essential to foster 
an effective therapeutic environment for patients. An HCP is an individual who offers 
preventive, curative, promotional, or rehabilitative health care services (Burgess et al., 
2017). HCPs’ perspectives or viewpoints affect service delivery and have the potential to 
impact effective patient interactions (Arnetz et al., 2015). Through adequate patient 
information and the appropriate perspectives of healthcare providers regarding patient 
needs, HCPs may be able to provide better care for patients. When HCPs have sound 
perspectives involving their patients’ conditions, including necessary cultural 
competence, an atmosphere exists to offer interventions that improve medication 
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compliance and establish the appropriate rate of attention or care (Greene, Hibbard, 
Sacks, Overton, & Parrotta, 2015). 
Improved health outcomes emerge when engagement between HCPs and patients 
is established with the appropriate perspectives and attitudes. Healthcare delivery 
depends on HCPs’ workforce performance (Panda, Thakur, & Zodpey, 2016). Hence, 
understanding the viewpoints of HCPs involving medication nonadherence among 
African American male psychiatric patients is essential to improve overall healthcare 
outcomes, enhance skills, and establish competence. In particular, attitudes, perspectives, 
viewpoints, and behaviors of HCPs are a source of health disparities (W. J. Hall et al., 
2015). Positive attitudes toward patients can influence HCPs’ level of care or service to 
patients and can cause implicit bias and healthcare outcomes (W. J. Hall et al., 2015). 
Empirical evidence suggests that HCPs’ perceptions can impede behavioral evidence and 
the level of care provided to patients, which can ultimately affect the level of care. Thus, 
understanding the perceptions of HCPs  is necessary to introduce positive social change. 
Background 
Various factors can affect nonadherence to medications in various populations, 
and psychiatric populations in particular. HCPs’ understanding of these factors can help 
break down major racial barriers that tend to impede healthcare provisions. African 
American patients often report provider bias and inequality of healthcare delivery (S. 
Taylor, Abramowitz, & McKay, 2012). Therefore, investigating provider perceptions is 
an expedient way to study socioeconomic factors that affect medication nonadherence in 
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this population. According to literature, factors such as patient attitude toward treatment, 
the seriousness of health condition, lack of trust in services provided, poor memory, and 
use of alternative therapeutic approaches, such as religious interventions, are of 
paramount importance in influencing medication nonadherence (Meichenbaum & Turk, 
1987). However, demographic and socioeconomic characteristics are also essential. HCPs 
who take care of African American male psychiatric patients need to be evaluated to 
understand their perspectives and attitudes toward their patients using a holistic scale. It 
is important for HCPs to truly understand these factors clearly so they can provide 
adequate care. 
It is not clear if HCPs identify psychiatric patients through stigmatization, labels, 
tags, discrimination, and other such factors; social and demographic elements are 
important determinants of medication nonadherence in populations such as African 
American male psychiatric patients. Thus, understanding the perspectives, viewpoints, 
and attitudes of HCPs is crucial to providing adequate healthcare services to African 
American male psychiatric patients and can help institute changes for these patients. 
Irrespective of the demography or ethnicity of patients, knowledge of HCPs’ viewpoints 
will help define the quality of care being provided, which in turn may increase the 
pressure on decision-makers to promote better working conditions for HCPs and higher 
recovery rates for patients. 
Although this subject of medication nonadherence has not been widely studied, 
attitudes, perspectives, and viewpoints of HCPs influence how they attend to patient 
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needs, with a corresponding relationship with treatment decisions, treatment 
nonadherence, and patient health outcomes (W. J. Hall et al., 2015). When HCPs hold 
negative viewpoints or are biased toward a patient, poor treatment may result, causing 
stress and avoidance of care, mistrust of the healthcare system, and nonadherence to 
medication among patients (Phelan et al., 2015). Also, negative viewpoints and stigma 
are major barriers to the treatment of psychiatric patients (Latalova, Kamaradova, & 
Prasko, 2014). Therefore, evaluating HCPs’ perspectives or viewpoints about patient 
needs is worthy of scientific study. 
Problem Statement 
A gap exists regarding understanding the quality of healthcare services and 
medication nonadherence among African American psychiatric patients. The relationship 
among race, treatment attitudes, and medication nonadherence of African American male 
psychiatric patients is largely unknown. Breaking down major racial barriers that tend to 
impede health care provision in African American psychiatric male patients is important. 
Little is known about racial variations in social and demographic factors that lead to 
medication nonadherence among psychiatric patients. Despite huge healthcare costs for 
psychiatric patients, medication nonadherence persists as a problem that needs to be 
investigated, especially among African American male psychiatric patients. 
Providers continue to provide care and services to patients, yet no measures target 
improving medication nonadherence for African American male patients, and African 
American patients often report provider bias and inequality in health care delivery. 
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Therefore, a study is needed to evaluate the perception of these providers (Lacro et al., 
2002). A detailed study is necessary to elucidate the perspectives or viewpoints of HCPs 
regarding medication nonadherence for African American male psychiatric patients using 
select demographic and socioeconomic characteristics. 
Although medication nonadherence is high among African American male 
psychiatric patients, perceptions of HCPs toward them have been largely unknown. Little 
is known about racial variations in social and demographic factors that lead to medication 
nonadherence among psychiatric patients. Wrong illness perceptions of patients’ needs 
by providers are likely to affect patient care. Therefore, understand the true situation of 
patient requirements with accurate HCP perceptions plays a vital role in overall health 
outcomes. Furthermore, provider perceptions toward these patients remains a neglected 
issue in research. Therefore, the perceptions, knowledge, and attitudes of providers 
toward African American male psychiatric patients are not known and need to be 
examined. 
Patients’ adherence to medication is established as patients leave 50, 70, 90, or 
100% gaps in their medication levels (K. C. Lee, 2013). Increased healthcare costs can 
lead to poor health outcomes (K. C. Lee, 2013). When patients do not comply with 
medication regimens, either by discontinuing or failing to follow medication instructions, 
the provision of seamless healthcare is impeded and health declines. Therefore, with each 
patient’s prescription, HCPs need to make concerted efforts to ensure respective patients 
understand the importance of medication compliance. The underlying factors and 
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impeding obstacles involved with provider viewpoints may play a huge role in solving 
this healthcare problem. 
Providers can prescribe medications but cannot assure patients will comply with 
drug instructions. For that reason, HCP perspectives need to be investigated to understand 
how and why patients do not adhere to medication instructions. Sociodemographic 
variables such as patient age, race, level of education, and marital status align with 
medication nonadherence in various populations (Jeon-Slaughter, 2012; Krousel-Wood, 
Muntner, Islam, Morisky, & Webber, 2009). Therefore, in this research, demographic and 
socioeconomic characteristics were gross family income, marital status, and age. 
Purpose of the Study 
The purpose of this study was to explore the perspectives or viewpoints of HCPs 
involving medication nonadherence among African American male psychiatric patients 
using gross family income, marital status, and age as sociodemographic factors in a 
Chicago-area hospital network. Five major factors influence medication adherence: 
patients themselves, medication type, HCPs, the healthcare system, and socioeconomic 
factors (S. Q. Lee et al., 2018). In the present study, I investigated provider perceptions 
and socioeconomic factors. 
This study explored perceptions of HCPs to help determine why age, marital 
status, and gross family income can impact medication nonadherence among African 
American male psychiatric patients. This research identified how attitudes and beliefs of 
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caregivers influence the level of medication nonadherence among African American 
psychiatric male patients. Identification of these determinants is important and necessary 
to provide mechanistic explanations and suggest possible public health policies and 
strategies that address the issue in this particular ethnic group. 
Nature of the Study 
This study was designed with a qualitative research methodology approach. In 
particular, I used a qualitative case study methodology to determine how HCPs view 
demographic and socioeconomic characteristics as determinants of medication 
nonadherence among African American male psychiatric patients. Qualitative case 
studies provide a comprehensive approach to evaluate complex issues and provide 
empirical and scientific rigor rather than a straight statistical correlation (Baskarada, 
2014). I conducted this dissertation using a purposeful sampling technique. In using the 
criterion sampling method of purposeful sampling, I conducted interviews with HCPs 
who met the inclusion criteria. 
The main instrument in this dissertation was one-on-one interviews with HCPs 
who met the inclusion criteria. The interviews aimed to seek responses from HCPs and 
obtain their viewpoints regarding demographic and socioeconomic characteristics that 
influence medication adherence (see Appendix A). 
In using a criterion sampling method for purposeful sampling, the chosen criteria 
were HCPs who were experienced in providing healthcare services to African American 
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male psychiatric patients in a Chicago-area hospital network. Study participants had at 
least 2 years of direct nursing experience with African American male psychiatric 
patients. Participants held current licenses. Study participants included four distinct 
provider groups: registered nurses, nurse practitioners, therapists/counselors, and 
physicians 
Because data cannot be collected from everybody or the entire given population 
for a research study, Morse (2000) suggested interviews with five to 50 participants 
would support an adequate qualitative study. G. A. Bowen (2008) said that a minimum of 
10 interviews should be sufficient to achieve saturation. Forty participant interviews were 
conducted before saturation was achieved in this study. Data accrued from 40 participants 
who met the inclusion criteria and all 40 participants’ interview data were analyzed to 
answer the research questions. 
Using a qualitative research methodology (semistructured interviews with HCPs), 
I explored the perspectives and viewpoints of HCPs. An HCP is an individual who offers 
preventive, curative, promotional, or rehabilitative healthcare services (Burgess et al., 
2017). The target population for this research was providers who offer services to 
improve the mental health of individuals or treat psychiatric illnesses in a Chicago-area 
hospital network. Accordingly, HCPs who participated in interviews in this study 
included doctors, nurses, psychiatrists, clinical psychologists, clinical social workers, 
psychiatric mental health nurse practitioners, mental health counselors, psychiatric care 
managers, or clinical social workers authorized to offer psychiatric health care, defined 
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by law. Although the scope and practices of these professionals differed, the identified 
HCPs in these roles all provided healthcare services to African American male 
psychiatric patients. 
Research Questions 
In this qualitative case study, I evaluated HCPs’ perspectives and viewpoints to 
understand factors that influence medication nonadherence among African American 
male psychiatric patients. In particular, I investigated gross family income, marital status, 
and age from HCPs’ perspectives. I interviewed eligible HCPs who met the study 
inclusion criteria to elucidate responses to answer the research questions (see Appendix 
A). The specific research questions follow: 
RQ1: What are the most important determinants of medication nonadherence 
among African American male psychiatric patients according to HCPs in a 
Chicago-area hospital network? 
RQ2: According to HCPs in a Chicago-area hospital network, how does age 
determine medication nonadherence among African American male 
psychiatric patients? 
RQ3: According to HCPs in a Chicago-area hospital network, how does marital 




RQ4: According to HCPs in a Chicago-area hospital network, how does 
socioeconomic status based on gross family income determine medication 
nonadherence among African American male psychiatric patients? 
Conceptual Framework 
Outcome expectations and self-efficacy empirical models based on social-
cognitive theory formed the conceptual framework to conduct this study. Of the several 
outcome expectations and self-efficacy empirical models, I used the theory of reasoned 
action and theory of planned behavior to systematically examine the various determinants 
of medication nonadherence for African American male psychiatric patients. This 
framework helps define the support needed to adhere to prescribed medication to 
strengthen patients’ intentions and ultimate actions to adhere to the prescribed therapy. 
Operational Definitions 
Medication nonadherence: Patients failing to take their medications as prescribed. 
Self-efficacy: The level of self-confidence and self-reliance of patients to adhere 
to medication regimes prescribed by HCPs (Zygmunt, Olfson, Boyer, & Mechanic, 
2002). 
Social-cognitive theory: The theoretical perspective in which learning by 
observing others is the focus of study. Social-cognitive theory is grounded in several 
basic assumptions. One is that people can learn by observing others. Learners can acquire 
new behaviors and knowledge by simply observing a model (Ajzen & Fishbein, 1980). 
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Psychiatric patients: Patients suffering from mental ailments or psychological 
abnormalities such as bipolar patients (Morisky, Ang, Krousel-Wood, & Ward, 2008). In 
this study, psychiatric patients are people experiencing disturbances or abnormalities in 
their mental systems. 
Significance of the Study 
This research was characterized by exploring how HCPs perceive demographic 
and socioeconomic characteristics as determinants of medication nonadherence among 
African American male psychiatric patients. HCPs need to identify and understand these 
variations to proffer the appropriate treatment regimen to accommodate racial disparities. 
This study helped explore how HCPs perceive African American male psychiatric 
patients and understand barriers or myths that impede treatment to ensure medication 
adherence, as well as avenues to eliminate existing racial barriers. 
Understanding the perspectives or viewpoints of HCPs can allow for a better 
understanding of cases of substandard healthcare delivery, which can lead the federal 
government to improve engagement practices in healthcare institutions. This study is 
important in thoroughly examining the issue of medication nonadherence and identifying 
the predominant factors that affect adherence among male African American psychiatric 
patients. Some persistent healthcare-services issues in the African American community 





This qualitative case study had two assumptions. First, I assumed African 
American male psychiatric patients had easy access to required medical amenities and 
help but hold higher rates of medication nonadherence compared patients in other racial 
groups. The last assumption was that the participants who were interviewed for this study 
provided responses that are honest, truthful, accurate, and useful to answer the research 
questions raised in this study. 
Limitations 
This qualitative research is limited in scope because it primarily focused on 
information provided by HCPs in a Chicago-area hospital network. This study is limited 
to the interview responses provided by participants who met the inclusion criteria to 
provide their perspectives or viewpoints on African American male psychiatric patients. 
Also, because this study involves only African American patients, social factors 
associated with medication-nonadherence determinants in other racial groups were not 
explored. 
Scope and Delimitations 
Delimitations are factors the researcher can control to narrow the range of the 
study. This study included only HCPs who met the inclusion criteria for healthcare 
delivery to African American male psychiatric patients. I conducted this study with HCPs 
through one-on-one interviews only in a Chicago-area hospital network with the primary 
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focus of African American male psychiatric patients. HCPs from other hospital network 
outside Chicago axis were not included. Although inclusion of other area hospital 
networks could have added credibility to this study, the intent of this study was to limit 
the scope to a single Chicago-area hospital network. 
Summary 
Chapter 1 included a background introduction to medication nonadherence as a 
public health issue in the general population of the United States and African American 
male psychiatric patients in particular. The chapter included the statement of the problem 
and the nature of the study. I mentioned the research questions, the purpose of the study, 
and the conceptual framework. I also described operational definitions to emphasize the 
public health significance of the study. Further, I provided the scope and limitations of 
the study. 
Chapter 2 provides a comprehensive review of the literature related to the 
research. In Chapter 3, I describe the methodology used for the study. Chapter 4 includes 
the results from the interviews, and in Chapter 5, I interpret those results, along with my 
conclusions and recommendations for future study and practice. 
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Chapter 2: Literature Review 
In Chapter 2, I provide a critical review of the literature related to the study. 
Medication nonadherence is a prevalent and costly healthcare issue in chronic disease 
patients in general and psychiatric patients in particular. Few studies described the extent 
of this pressing public health problem in minority populations such as male African 
American psychiatric patients. 
Nonadherence to medication is a multifaceted challenge linked with the 
therapeutic relationship between medical professionals and patients, medications, and 
patients and their conditions, which may greatly impede the maintenance of sound health. 
Medical professionals contribute to nonadherence through failures to prescribe simple 
routines, explain the advantages and side effects of medications, and consider patients’ 
lifestyles or medication costs. Also, health professionals and patients mentioned 
forgetfulness, the existence of other priorities, decisions to omit other doses, deficiency 
of information, and other emotional considerations such as psychological issues that 
emanate from medication nonadherence. Supervision by medical trustees in situations of 
patients’ absence of insight is a major factor in adherence (Zygmunt et al., 2002). 
Nonadherence to psychiatric treatment management weakens treatment-
management effectiveness, increases the risk of setbacks, and can lead to damaging 
results because of the inability to maintain proper health status (Bulloch & Patten, 2010). 
Healthcare professionals previously resorted to educational programs, family therapeutic 
programs, and community-based measures to successfully enhance adherence (Zygmunt 
et al., 2002). The extent of this pressing public health problem has been understudied 
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among minority populations such as male African American psychiatric patients, with 
limited literature discussing nonadherence. 
In this chapter, after first providing the search strategies and databases, I present a 
survey of literature related to established or hypothesized determinants of medication 
nonadherence. Then, I describe the theoretical foundation guiding the study and critically 
review the context of medication nonadherence among psychiatric populations. This 
chapter concludes by identifying a knowledge gap regarding the determinants of 
medication nonadherence among African American male psychiatric patients. 
Databases and Search Strategies 
In searching for the relevant literature for the study, I used the following 
databases: EBSCOhost, PsycINFO, Google Scholar, ScienceDirect, ProQuest Central, 
and PubMed. I used the following keywords and phrases: medication nonadherence, 
perceptions, psychiatric patients, African American men, healthcare providers, and 
healthcare viewpoints. The various determinants of medication nonadherence can be 
categorized as socioeconomic factors, patient factors, healthcare-system factors, therapy 
factors, and condition factors (World Health Organization [WHO], 2003). Next, I survey 
the various dimensions and determinants of medication nonadherence. 
Factors Affecting Nonadherence 
The five dimensions of nonadherence for medications are socioeconomic factors, 
the healthcare system, patient condition, therapy, and patient (WHO, 2003). I classify 
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each of those conditions in the context of medication adherence among African American 
male psychiatric patients. 
Socioeconomic Factors 
Due to the stereotypical image of psychological issues among African Americans, 
patients may feel embarrassed or ashamed of adhering to medication routines, treatments, 
and therapies. However, adherent patients encounter some levels of social support 
(Maguire, Hughes, & McElnay, 2008). This social support is not sufficiently motivating. 
Instead, sympathy from the community creates further psychological issues for patients. 
Particularly among the populations that were the concentration of this study, discussing 
ones’ health issues to gain social support may be culturally unthinkable. Furthermore, 
patients may expect society will see that they have psychological disorders because of 
having financial or personal issues and stress. 
Healthcare System 
The frequency of dosage taken by an individual patient over a specifically 
prescribed period determines the percentage rate of medication. Some HCPs described 
this rate as the number of medications or pills taken in a day (Burnett-Zeigler et al., 
2014). Persistence involves the continuity of taking one medication for a specific period 
and is the type of medicated therapy used in the treatment of patients with chronic 
diseases (E. M. Williams et al., 2014). The level of adherence is very high in patients 
suffering from acute diseases compared to those with chronic diseases; the fall in 
adherence in patients with chronic diseases could be easily observed after continuous 
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treatments of 6 months (E. M. Williams et al., 2014). A problem observed in the United 
States and the UK provides an example: 50% of patients continued statins for 6 months 
whereas 30 to 40% continued for 1 year (E. M. Williams et al., 2014). 
Determination of patient adherence to antihypertensive medications in outpatient 
settings is an essential initial step for clinicians in understanding the effectiveness of the 
medicines they recommend, recognizing obstructions to treatment, and enhancing 
psychological well-being. Hawkshead and Krousel-Wood (2007) supported the use of 
short self-report measures, such as the Morisky Medication Adherence Scale (MMAS), to 
provide data on components influencing adherence that are valuable in clinical settings, 
such as distraction and medication side effects. The relationship between the MMAS and 
filling medication was not without problems, perhaps due to the weaknesses of self-report 
measures and the powerlessness of pharmacies to provide information that assesses the 
subtleties of medication-taking behavior (Kim, Han, Hill, Rose, & Roary, 2003). The 
relationship of the MMAS with uncontrolled psychological-disorder preservation and the 
genuine relationship between low adherence and poor mental health is likely more 
prevalent than reported (Kim et al., 2003). 
Several investigators observed the influence of pharmacist interventions on 
patients’ adherence to medications. Seven investigations showed a positive influence, 
whereas five showed no effective influence between control groups and tested groups 
(Hattingh, Scahill, Fowler, & Wheeler. 2016). Further, eight types of researchers 
observed a negative and depressive aspect from the intervention of the pharmacist on the 
patient (Hattingh et al., 2016). Literature noted that researchers worked to observe and 
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study psychological functions such as mood disorders. Another six studies of those 
reported showed no statistical change in adherence and depressive symptoms (Hattingh et 
al., 2016). In previous research, Guillaumie et al. (2015) observed and reported a variable 
improvement, though not very significant, when pharmacists provided information to 
patients. Four studies conducted by Guillaumie et al. showed improvement in adherence 
and the earlier symptoms of patients. Another disclosed aspect of pharmacists’ 
intervention was an improvement in patients’ drug-related knowledge (Guillaumie et al., 
2015). 
In another study, researchers also conducted conversations with patients two-third 
of the time they issued prescriptions (Conn, Enriquez, Ruppar, & Chan. 2014). When 
pharmacists provide medications, they have a clear opportunity to communicate 
pharmaceutical experience and advice on the drugs prescribed by physicians. General 
communication involves patients’ concerns such as the side effects of the drugs, the 
interaction between drugs, and a cost comparison. However, pharmacists do not tend to 
indulge in deeper talk about expectations, understandings, and patients’ satisfaction levels 
(Horne et al., 2013). Steps to build the formal communication skills of pharmacists such 
as language, style, and supportive talks may help create a bridge to patients, rendering the 
collaboration more like a partnership than a paternalistic approach (Stepleman, Decker, 
Rollock, Casillas, & Brands, 2014). 
Healthcare Providers’ Viewpoints 
HCPs aim to provide services that improve patients’ health, longevity, and quality 
of life through the provision of patient‐centered care, without bias or hesitation. 
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However, in doing so, it is imperative to eliminate HCPs’ behaviors that discriminate 
against their patients (Phelan et al., 2015). HCPs have an important role in providing 
effective treatment regimens for patients. When HCPs perform at their optimum level, 
they accelerate patient recovery and improve patient satisfaction (Tsai, Orav, & Jha, 
2015). In particular, attitudes, perspectives or viewpoints, and behaviors of HCPs have 
been a source of health disparity (W. J. Hall et al., 2015). Positive attitudes toward 
patients can influence HCPs’ level of care or service to patients and can cause implicit 
bias and health care outcomes, if not properly managed (W. J. Hall et al., 2015). 
HCPs’ performance toward patient recovery is one of the key metrics of patient 
satisfaction. Although this topic of medication nonadherence among African American 
male psychiatric patients has been studied, researchers showed that perspectives or 
viewpoints of workers induced how HCPs attend to patients’ needs, with a corresponding 
relationship to treatment decisions, treatment adherence, and patient health outcomes. 
The level of stigma, stereotype, and other societal classifications by HCPs toward 
patients impacts the level of care provided to patients (Phelan et al., 2015). When HCPs 
hold negative perspectives, viewpoints, or bias toward patients, they may provide poor 
treatment that can cause stress and avoidance of care, mistrust of the health care system, 
and poor adherence among patients (Phelan et al., 2015). Hence, evaluating HCPs’ 
perspectives or viewpoints about patient needs is worthy of scientific study. 
African American patients do not trust the health care system (Boulware, Cooper, 
Ratner, LaVeist, & Powe, 2016). In cases where divergent cultural experiences exist 
between patients and care providers, understanding of social and demographic factors is 
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essential to enhance patient care and accelerate patient recovery. Of particular mention, 
people of color and minority racial groups have reported cases of health disparity and 
lesser health outcomes due to HCP bias or negative perspectives or viewpoints (W. J. 
Hall et al., 2015). HCPs may harbor attitudes and behaviors that hinder equal health care 
access to all patients, irrespective of race. HCPs’ perspectives or viewpoints are often 
activated by instinct, based on implicit factors, and can influence behavior without 
conscious volition, thereby impeding appropriate health care delivery (W. J. Hall et al., 
2015). Thus, HCPs’ perspectives or viewpoints may play a vital role in medication 
nonadherence for African American male psychiatric patients evaluated in this study. 
Overview of African American Male Psychiatric Patients 
African American male psychiatric patients have an average age of 41 years and 
tend to be unemployed (Hudson, Eaton, Banks, Sewell, & Neighbors, 2018). This group 
of patients also tend to be unmarried and never married. Patients in this group mentioned 
that mistrust of the health care system and stereotypes or stigma contribute to their 
medication nonadherence or lack of desire to seek treatment. Coupled with certain 
prejudicial beliefs and sentiments about mental illness, these factors hinder these patients 
from seeking help (Hudson et al., 2018). Only 14% of participants in the Hudson et al. 
(2018) study agreed they were consistent and compliant in their medication use, 
rendering medication nonadherence in African American male patients a strong public 
health problem. 
With 20% of African Americans more likely to experience serious mental health 
problems than the general population, the propensity to remove barriers that inhibit 
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adequate health care should be strengthened (McKirnan et al., 2016). HCPs would be 
more effective if they avoid negative viewpoints and stigmatization of patients through 
biased perspectives. Social determinants can affect medication nonadherence in 
psychiatric patients; hence, HCPs need to have true perspectives or viewpoints and 
opinions to offer the necessary treatment and care. In the present study, social 
determinants were evaluated as age, gross family income, and marital status. 
Psychiatric patients who are married are more susceptible to be compliant with 
their medication protocol than patients who are not married (W. J. Hall et al., 2015). 
Marital status as a social factor can affect medication nonadherence. Hence, knowledge 
of these factors is imperative for HCPs, enabling them to adopt measures that are 
effective in eradicating medication nonadherence for psychiatric patients. 
As previously discussed, cultural variations and social factors often induce how 
psychiatric patients behave. The act of seeking help for mental disorders is often viewed 
as a sign of weakness, especially for African American men (Murray et al., 2006). HCPs 
are tasked with high responsibility to encourage medication compliance for these 
patients. Understanding the racial and cultural variations particular to African American 
male psychiatric male patients is crucial to seeking improved medication adherence. The 
efforts and influence of HCPs are crucial to the identification and treatment of mental 
disorders in African American patients to enhance medication compliance. 
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Condition and Therapy 
Reduced concern about medications impacts the incidence of adherence as well 
(Horne et al., 2013). Horne et al. (2013) conducted a meta-analysis of the literature, 
demonstrating that individuals with fewer worries about their treatment have better levels 
of adherence to treatment. Furthermore, health-minded care suppliers need to examine 
social worries about medicines related to the psychological well-being of patients from 
ethnic-minority populaces. Concerns regarding the side effects of medication, for 
example, loss of sexual activity or inclinations to use customary remedies, may offer one 
clarification for the reduced level of medication adherence among African Americans 
suffering from psychological disorders. 
Many HCPs have prescribed complex medication routines and then failed to 
explain their advantages, creating the lowest level of adherence in patients; these HCPs 
also do not consider patients’ lifestyle, which may also serve as a barrier to adherence. 
Improved communication between the HCP and the patient could result in greater trust in 
their relationship (Sin & DiMatteo, 2014). Other factors, such as social support, weather, 
poverty, migration, homelessness, and socioeconomic status also play a vital role in 
helping and creating barriers to adherence (Murray et al., 2006). 
Patients 
The ability to achieve patients’ medication self-efficacy emphatically affects 
adherence to psychological or antihypertensive medications (Schoenthaler, Ogedegbe, & 
Allegrante, 2009; Warren-Findlow, Seymour, & Brunner Huber, 2012). Patients’ 
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adherence level and intensity tend to improve if they are psychologically ready to take 
medications under a variety of circumstances and environments without insecurities. 
Adherence to medication emerged in other diseases and physical ailments such as 
rheumatoid joint inflammation, depression, and hypertension in African American 
patients (Kressin et al., 2007). 
Anxiety is a major determinant of adherence to lifestyle (Serour, Alqhenaei, 
Al-Saqabi, Mustafa, & Ben-Nakhi, 2007). When patients visit their HCP, the HCP 
prescribes some medication aimed to become part of the routine of that patient, dubbed 
the medication regimen (Nieuwlaat et al., 2014). Most HCPs use the term adherence 
rather than compliance to express the HCP’s medication order passively, showing that the 
treatment of the patient is not based on this therapeutic association or any contract 
recognized by the HCP and the patient (Nieuwlaat et al., 2014). Both terms play a vague 
and deficient role in patient medication-taking behaviors. Patients’ usage of these terms 
could cause the branding of those patients who do not consume every medicine at the 
prescribed time, which may weaken their relationship with their HCP, resulting in 
stereotyping and a negative relationship (Nieuwlaat et al., 2014). 
If patients follow their prescriptions routines in a normal manner, they could 
obtain effective results through their medication (Burnett-Zeigler et al., 2014). In 
contrast, nonadherence could be described as intentional or unintentional behavior. If the 
patient does not take medicine due to amnesia or dexterity, this type of nonadherence is 
unintentional. Nonadherence could be intentional when a patient decides to take 
medication based on presumed results rather by taking it on time as prescribed by the 
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HCP. Intentional adherence also depends on past results, motivation, and appraisals of 
the relevant medicine. 
In a 2014 study, researchers studied patients’ beliefs, using the necessity-concerns 
framework to operationalize important views that affect the adherence of patients (E. M. 
Williams et al., 2014). These beliefs clearly explain adherence, based on necessities 
evaluated based on their diseases (E. M. Williams et al., 2014). Evidence from this study 
showed that many beliefs control intentional or unintentional adherence factors in 
patients. The occurrence of unintentional and intentional nonadherence depends on the 
dosage of the medicine missed at certain times and durations. For example, a patient may 
miss a dosage of medicine at a particular time in a day or a patient in the same pattern 
could miss taking medication for several days or may stop taking a medicine completely. 
Patients could be nonadherent by reducing or increasing the dose of relevant 
medicine prescribed the HCP, rather than not taking it (Markell et al., 2014). Thus, 
patients show intentional and unintentional behaviors of adherence toward prescribed 
medication (Markell et al., 2014). Medication possession rates were defined 20 years ago 
to show the degree of patients’ behaviors toward medication. The number derives by 
dividing the total number of days the patient has access to medication by the total number 
of prescribed days (Rosen et al., 2016). 
Health professionals have a marked need to change traditional mindsets and 
respect the autonomy, mentality, and privacy of patients (Stepleman et al., 2014). HCPs 
must work to understand the importance of patients’ priorities over prescription 
instructions. Strong arguments favor the active participation of patients in medical 
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processes and decisions about their treatment; these arguments have led to progressive 
concepts and ideologies such as shared decision-making and patient-centeredness, 
wherein HCPs encourage patient participation in the entire treatment process (Stepleman 
et al., 2014). 
These arguments also laid the foundation for the developmental process to 
involve the patient in their health care, leading to various terminologies and definitions 
about the involvement of the patient (Hattingh et al., 2016). Some terms include patient 
involvement, patient participation, concordance, informed decision-making, and 
evidence-based patient choice. Charles et al. (as cited in Hattingh et al., 2016) presented 
one of the most authentic and widely accepted descriptions of shared decision making 
(SDM). Charles et al. (as cited in Hattingh et al., 2016) presented the idea of SDM as a 
model in which consultations involved two-way communication and the physician and 
patients collaborate to make decisions. A similar scenario is required for the concordance 
to take place: a need exists for two-way, collaborative communication between the 
patient and the physician, exchanging personal beliefs, views, and priorities about 
medications. 
Another important aspect of accordance is that it does not refer to the measure of 
compliance (Conn et al., 2014). Compliance is the measure of a patient’s behavior as it 
aligns with the instructions of the physician. Concordance, however, is a variable 
measuring a two-way process of mutual consultation; that is, SDM: a partnership 
approach with the physician respecting a patient’s beliefs (Conn et al., 2014). Hence, in 
SDM, all involved HCPs regard the patient as a partner in making deliberate or 
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collaborative decisions about treatment and medications. SDM encourages patients to be 
more motivated to follow the doctor’s instructions and prescriptions (Conn et al., 2014). 
Without such collaboration, patients may continue to refuse to engage in any treatment 
(Bray, Thompson, Wynn, Cummings, & Whetstone, 2005). 
A close and significant association exists between a patient’s participation in 
medical treatment, improvement in adherence to medication regimens, and diminished 
depressive mental state (Brody et al., as cited in Bray et al., 2005). Negotiations with 
patients on medications result in better adherence to medication regimens and results 
(Sandra et al., 2002, as cited in Bray et al., 2005). Other positive influences of bipolar 
interventions are the increased satisfaction level of the patient and an enhanced level of 
self-esteem (Burnier, Wuerzner, Struijker-Boudier, & Urquhart, 2013). A similar type of 
positive influence was reported as a result of patient-centered care (Burnier et al., 2013) 
and secondary decision aids such as websites, pamphlets, and videos, to make deliberate 
decisions with the involvement of the patient (Bray et al., 2005). The ratio of patients 
who inclined toward discontinuing medications diminished as they chose and prioritized 
treatment (Bray et al., 2005). 
Amid this progressive research, a gap needs to be bridged. Regardless of the 
identification of the various factors that reduce nonadherence to mediations for those in 
depressive states, little research sought to overcome these factors and involve patients in 
treatment. Though studies regarding SDM are in the developmental stages, they have 
provided encouraging information on its effectiveness in addressing mental health. For 
example, Stovell, Morrison, Panayiotou, and Hutton (2016) conducted a brief study on 
28 
 
SDM and reported a higher level of satisfaction and effective outcomes from the 
experimental group, compared to the controlled group, over 2 years. Croft et al. (2015) 
conducted an experiment of a similar nature, producing agreement with outcomes in a 
period of 3–12 months. Légaré et al. (2014) analyzed the SDM model and reported that 
the most dominator factor of the model is the dyad between the physician and patient, 
neglecting all the other possible involvements of healthcare professionals. Thus, 
researchers presented a need to build a more innovative model to guide healthcare 
professionals. 
Measuring Adherence and Healthcare Providers’ Perspectives 
The target population for this study was health caregivers to African American 
men living with psychiatric disorders in a Chicago-area hospital network. I sourced the 
sample population from caregivers in facilities nurturing people who met the inclusion 
criteria in a Chicago-area hospital network. The perspectives or viewpoints of HCPs 
affect collaboration with patients and how they provide treatment regimens; hence HCPs’ 
perspectives are very important in understanding the complexity of human behavior. 
When people behave based on their viewpoints, their actions can be predicted and 
based on their perceptions of what reality is, not on reality itself (Hansen et al., 2009). 
Viewpoints or perspectives lead people to how they act in the environment; thus, HCPs 
must have accurate perceptions of patients to promote evidence-based treatment that 
eliminates medication nonadherence in this population. 
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Perspectives help individuals understand and internalize their experiences, 
making it important for HCPs to avoid common problems and processes for measuring 
medication nonadherence that may not be founded in fact or reality. When making 
decisions on medication nonadherence toward African American male psychiatric 
patients, individual patient plans must be designed through the lens of each patient’s 
unique resources and needs rather than the ambiguity of HCP perspectives. 
Perspectives are how individuals personally receive, organize, and interpret 
impressions to form an opinion and give meaning to their environment (Ginter, Duncan, 
& Swayne, 2018). Perspectives of HCPs to medication nonadherence involve the abilities 
of HCPs to identify, communicate, and counsel patients to improve adherence to 
medications. The ability to achieve better outcomes is a key health care indicator. 
Nonadherence to medication can result in worse clinical outcomes that may be 
followed by increased health care expenditures (Hansen et al., 2009). Clinical pathways 
must be embraced that evaluate the perspectives and viewpoints of HCPs to support the 
fundamental purpose of improving the quality of care. Perspectives help HCPs define 
their character and attitude on how to tend to patients, ultimately inducing successful 
interventions aimed at improving medication compliance for African American male 
psychiatric patients. 
Consequences of Nonadherence 
Medical involvement in a patient’s therapy is the prescribing of relevant 
medicine, which accounts for 15% of the total expenses of the therapy. According to 
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research, the National Health Service spent £8 billion on medicines in England in 2005 
(Cooper et al., 2016). The usage of medicines is increasing markedly, according to a 
survey. In England, 13.1% of prescriptions were found for every person in 2003, showing 
an increase of 40% compared to the previous decade record (Cooper et al., 2016). 
Researchers found a variation in medication regimens ranging from 17% to 80%, due to 
the variety of illness, routine factors, the methodology applied, and even the methods of 
testing and measuring adherence (Stepleman et al., 2014). 
Similarly, nonadherence can lead to severe illness and death and could increase 
healthcare costs (Stepleman et al., 2014). According to a sample, nonadherence could 
result in patients’ relapse to schizophrenia and a marked decrease in left ventricle 
pumping in those suffering from heart diseases (Stepleman et al., 2014). Patients who do 
not care to comply with their medication routine while suffering from heart failure have a 
mortality rate 1.95 times higher than those who are adherent. Similarly, those who stop 
taking β-blockers have an initial rise in risk for coronary heart disease that is 4.5 times 
greater than that of patients who continue with therapy (Interian, Lewis-Fernández, & 
Dixon, 2013). Nonadherent patients are hospitalized 2.5% more than patients adherent to 
their medication regimen (Interian et al., 2013). 
One factor that increased admission numbers in U.S. hospitals was poor 
adherence, leading to expenditures of $100 billion annually (Interian et al., 2013). 
Nonadherence is charged with approximately 125,000 deaths annually, along with 11% 
of hospital admissions. Of recruited nursing staff, 40% lack knowledge of the importance 
of adherence to medical therapy (Shim et al., 2017). Medical problems surveyed in the 
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United States due to this factor cost the government about $177 billion per year, directly 
and indirectly, increasing expenditures to pharmaceutical firms. Every year, 140 million 
prescriptions costing $2.8 billion are wasted and left unfilled. Thus, 30 to 50% of 
prescriptions cannot achieve their medical goals, reducing the benefits of treatment (Shim 
et al., 2017). 
According to a recent survey across U.S. and Saudi patients, children adhered to 
medical regimens at 61.8 and 64.9%, respectively (Conn et al., 2014). At Taif Chest 
hospital in Saudi Arabia, 43.8% of tuberculosis patients were found to comply, but 75% 
did not attend initial clinical checkups. In Tabuk, Saudi Arabia, 53% of hypersensitive 
patients were found to comply with their regimens, mainly men, but older people did not 
comply, rendering their blood pressure uncontrollable (Conn et al., 2014). 
Medication Nonadherence in African American Psychiatric Patients 
Of the five dimensions of adherence, the most relevant and effective is the 
socioeconomic dimension. Patients’ socioeconomic status not only affects their self-
esteem and self-recognition but also profiles or stereotypes them into a specific category 
(Bean, Stone, Badger, Focella, & Moskowitz, 2013). For instance, a poor African 
American single man is less likely to adhere to medicine because of his lower self-esteem 
and lack of financial support. Similarly, physicians or the healthcare staff stereotype 
patients based on their ethnicity, race, and socioeconomic status (Bean et al., 2013). 




A need exists to improve methods for tending to treatment adherence among 
hypertensive African Americans patients in Western nations. Agyemang et al. (2005) 
recommended that interventions to bolster ideal adherence to endorsed medications is 
more fruitful in this populace if health-minded experts discuss patients’ worries about 
medications and establish trust in the capacity to take medication (self-efficacy). Khatib 
et al. (2014) recommended that this instructive approach prompts superior 
comprehension of hypertension, and mollifies worries about the related dangers of 
hypertension, along with mindfulness that hypertension can be controlled but not cured. 
Instruction ought to focus on the understanding that hypertension is not an ailment in 
itself, but rather that treatment is important to avert later illness that can be avoided. 
Patients often stop taking medication or stop actualizing lifestyle changes when 
they believe their hypertension is cured. These misguided judgments about the nature and 
course of hypertension can negatively influence treatment adherence (Khatib et al., 
2014). Shared medical appointments may mitigate these misguided judgments and appear 
to have a positive effect. As worries about medication and its side-effects prompt poor 
adherence and patients often do not discuss their dread of side-effects, specialists ought to 
examine side-effects regularly (Bray et al., 2005). 
An examination of the profile of medically nonadherent African American 
patients with hypertension proposed that youthful age, smoking, and female sex related to 
nonadherence; in contrast, conjugal status, education level, physician advisement, and 
family components aligned with compliance. Social and noteworthy elements may add to 
nonadherence. For instance, physicians are often from social or ethnic groups that differ 
33 
 
from their ethnic-minority patients, potentially prompting communication issues and 
ensuing nonadherence. Corbie-Smith (1999) and Freedman (1998) also proposed African 
American patients do not trust medical personnel due to the Tuskegee syphilis probe of 
African American men, causing African Americans to eschew participation in research. 
Meichenbaum and Turk (1987) proposed five areas of a hindrance to adherence. 
First, patients may have negative states of mind toward treatment, including when they 
have serious ailments, depression, lack of trust in healing facilities or physicians, poor 
memory, poor perusing capacity, and the use of optional methodologies, such as religious 
interventions. Second, physicians may have an uncollaborative style. Third, malady and 
side effects obstruct adherence. Inert or moderately asymptomatic infections and having 
numerous sicknesses can confuse treatment. Fourth, treatment characteristics include 
poor treatment efficacy and unfriendly side effects. Finally, sociological hindrances 
constrain accessibility to care, including high costs, expecting to require senior care, 
being segregated, and having low social support. Medical nonadherence is most likely 
affected by various of these five constraints. 
Few studies have contrasted African American and Caucasian patients and 
systemic lupus erythematosus on rates of nonadherence. In the literature search, no other 
studies were discovered that considered how essential it is to know how ethnic groups 
contrast on obstructions to adherence. It is essential not to assume all ethnic groups 
obstruct adherence for the same reasons. Patients, physicians, illnesses, treatments, or 
natural boundaries may influence adherence diversely. Thus, ethnic-group members may 
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require different motivations to gain adherence, requiring ethnic-specific, as well as 
person-specific interventions to change those boundaries and enhance adherence. 
Lifestyle changes, including evading the sun, maintaining a strategic distance 
from pregnancy, and making and keeping medical referrals, differ markedly among 
patients and conceivably cross-ethnic groupings. For instance, Caucasian patients with 
lupus are more often photosensitive than are African Americans; in this manner, ethnic 
groupings require distinctive guidance to maintain a strategic distance from the sun. 
Significantly, researchers may evaluate these nonadherence areas independently, as they 
often relate only minimally. 
Conceptual Framework 
I used outcome expectations and self-efficacy empirical models based on social-
cognitive theory as the framework for conducting the present study. Of the several 
outcome expectations and self-efficacy empirical models, I used the theory of reasoned 
action and theory of planned behavior to systematically examine the various determinants 
of medication nonadherence in African American male psychiatric patients. The patients’ 
perspectives or viewpoints that adherence is effective establishes the intention to adhere 
to medication. Moreover, the support needed to adhere to prescribed medication 
strengthens the patient’s intention and ultimately the patient’s actions to adhere to the 
prescribed therapy. 
Aligned with observations from two observational and one randomized study, a 
positive association emerged between personal beliefs and the possibility of adherence to 
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antidepressant medications (Horne et al., 2013). These theories concern an HCP’s 
personal beliefs about the usage of medications and effects to influence the viewpoint of 
the patient. 
Health Communication Model (HCM) 
The HCM explains adherence as the complicated combination of personal traits 
and behaviors that highly depend on the patient’s knowledge of the entire process of 
treatment, satisfaction level with the chosen treatment, and the established relationship 
between the patient and the practitioner (Conn et al., 2014). Precisely put, the appropriate 
and competent skills of the practitioner can motivate the patient to change his negative 
behavior and push him to actively participate to build an effective relationship with the 
practitioner (Conn et al., 2014). 
The term adherence can be attributed to the dynamic set of behaviors and a 
continuous process of treatment. As described earlier, adverse perspectives or beliefs can 
change with the proper intervention, support, and most importantly, the patient’s 
experience throughout the treatment processes. Hence, it is extremely important to 
understand that the initial image, impression, and contact with the practitioner will 
determine further contact with the patient (Conn et al., 2014). 
The Theory of Planned Behavior 
The theory of planned behavior is an extension of the theory of reasoned action, 
initially proposed by Ajzen (1985). I applied this theory to observe and analyze the 
association and relation between and among patients’ beliefs, intentions, and behaviors. 
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This theory suggests that three distinct beliefs define human behavior: behavioral beliefs 
about the possible consequences of behavior; normative believe related to expectations 
from other humans, and control beliefs. These three basic beliefs are determinants of the 
general behavior of the patient (Zemore & Ajzen, 2014). 
Horne’s Theoretical Model 
This model suggests and reports a firm relationship between a patient’s personal 
beliefs and their adherence to medications (Horne et al., 2013). Thus, the patient’s beliefs 
must be considered before managing compliance issues. The objective of antidepressants 
as necessity-minus-concerns associates the level of nonadherence and outcomes. The 
adherence level is at its peak when concerns are greater than necessities, but at the lowest 
when concerns exceed necessity (Horne et al., 2013). 
Lower levels of adherence also align with high scores on the specified Concern 
scale of the Medicines Questionnaire (Horne et al., 2013). Researchers observed that the 
better and efficient involvement of the patient in the decision-making processes of the 
treatment results in a better level of adherence, increased satisfaction, and better results 
from the medications (Le et al., 2016). Similar results accrue from the proper intervention 
of practitioners (Le et al., 2016). 
The HCM helps in understanding the factors and dimensions that affect 
communication between HCPs and patients to determine the level of medication 
nonadherence. Similarly, the theory of planned behavior helps in understanding instances 
and factors affecting the lack of medication adherence in patients and how HCPs can help 
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patients improve their medication adherence. The literature review conducted 
demonstrated the need to investigate the determinants of medication nonadherence in 
general and in minority populations such as African American psychiatric patient 
populations in particular. 
Implications of Social Change on Medication Nonadherence 
Social change broadly refers to alterations in the social order of a society, 
including social behaviors and relationships (Bosworth, 2012). Social change accrues as a 
result of several societal courses such as changes in the ecosystem, technological change 
that creates new social behavior and attitudes, and social relations. Political, ideological, 
or economic movements initiate social change (Bosworth, 2012). This change may come 
in the form of altered levels of social support or altered social behaviors. 
Social support may be defined as the actuality or perspectives that one is cared for 
and is part of a social network that is supportive. Social changes in support may come in 
the form of increased or reduced social support. An increase in support helps ensure 
greater adherence to medications; in contrast, decreased support reduces patients’ 
propensity to adhere to prescribed medications (Bosworth, 2012). This is because an 
increasingly involved multitude helps patients cope with feelings more than does lack of 
a sense of belonging. 
Social support further encourages patients to progress through periods of 
medication use without thoughts of nonadherence. Social support helps remind patients 
of particular times to take medication and the importance of adherence (Olson, Young, & 
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Schultz, 2016). Technological change has made social support easier by enabling 
interactions between the patient and a user interface that reminds the patient of the time 
to take medication and further encourages adherence (N. J. Hall, Rubin, & Charnock, 
2013) 
Social change may also come in the form of a change in social behavior. Social 
behavior includes basic human behaviors ranging from physical and emotional aspects to 
the influence of ethics, genetics, and culture (N. J. Hall et al., 2013). Social support works 
positively to develop a more medication-friendly patient who understands the importance 
of adherence and the demerits of nonadherence (N. J. Hall et al., 2013). 
Following the provision of social support, medical experts can strategize to 
cultivate behaviors that encourage adherence and condemn nonadherence, working to 
further ensure patients adhere to medication regimens (Bosworth, 2012). Social change 
further works toward changing attitudes of people comprising the social structure (N. J. 
Hall et al., 2013). Once a patient’s attitudes toward their medications and illness change, 
their frequency and pattern of use of medication changes (Daley & Salloum, 2001). Once 
a patient develops a positive attitude toward medication and their particular ailment, they 
are in a better position to maintain adherence to the prescribed medication and the 
probability of getting well again (Daley & Salloum, 2001). Thus, social change can more 
positively impact psychiatric patients by influencing their attitudes, behaviors, and 
viewpoints on matters regarding social support (Daley & Salloum, 2001). In turn, social 
change can have an overall effect on their use of medication and, subsequently, on 




In Chapter 2, the review of literature related studies on medication nonadherence 
in the general population and African American psychiatric male patients in particular. In 
this chapter, I evaluated the correlation with perspectives or viewpoints of HCPs to 
African American male psychiatric patients. The review of literature established that the 
problem of medication nonadherence is widespread and studied extensively, whereas 
very few studies addressed issues of medication nonadherence in African American men 
who are psychiatric patients. This lack is irrespective of the fact that the issue of 
nonadherence is more prevalent in African American male psychiatric patients. 
In critically reviewing the literature on sociocultural and personal factors that 
affect medication nonadherence, I considered the five dimensions of nonadherence. 
Based on the literature review conducted, very few studies examined the determinants of 
medication nonadherence among African American male psychiatric patients. In Chapter 




Chapter 3: Research Method 
As discussed in Chapters 1 and 2, how HCPs perceive African American male 
psychiatric patients can affect medication nonadherence and the type of overall care 
being provided to this population. Hence, it is important to align and correlate the 
perspectives or viewpoints of these HCPs with patient social and demographic factors 
that might conflict with medication adherence. The lack of previous in-depth research 
that evaluated African American male patients suggested this topic is a viable subject to 
review and worthy of a doctoral study. Because medication nonadherence presents a 
strong problem in maintaining optimal health outcomes, if HCPs’ viewpoints are better 
understood, the provider-to-patient relationship could improve medication compliance 
and initiate better health outcomes. 
Purpose 
The purpose of this qualitative case study research was to explore the viewpoints 
of HCPs toward medication nonadherence among African American male psychiatric 
patients using gross family income, marital status, and age as sociodemographic factors 
in a Chicago-area hospital network. In this chapter, I describe the study design, sampling 
approach, study rationale, instrumentation and study tools, data analysis, and ethical 
considerations. I include the rationale regarding why the selected study design was 
appropriate. I restate the research questions and provide a detailed description of data 
analysis methods used to answer the research questions. I also discuss sample-size 
estimations for determining saturation and any potential limitations related to the study 
design and data sources. 
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Research Design and Rationale 
This qualitative case study research involved exploring HCPs to understand their 
underlying perspectives and viewpoints regarding African American male psychiatric 
patients. Because this study aimed to gain deeper knowledge, in-depth understandings, 
thoughts, and viewpoints, a qualitative study design was more appropriate than a 
quantitative study design. The qualitative design is more applicable when there is a need 
for explanation and to establish relationships among existing variables or factors. 
Because this was nonexperimental case-study research, the qualitative study design was 
applicable and selected as appropriate. 
Case Study Research 
It is essential to select a research approach that enables the appropriate data-
collection process to answer the research questions in a study (Creswell, 2009). Creswell 
(2009) identified five types of qualitative approaches for a qualitative study: ethnography, 
grounded theory, narrative study, phenomenological study, and case study. Because this 
study evaluated African American male patients, I considered the idea of an ethnographic 
study. However, the ethnographic study design would be inappropriate because this study 
did not concern the lifestyles of African Americans in general; rather, this study aimed to 
examine this ethnic group regarding medication nonadherence. Therefore, ethnography 
was unnecessary for this study and not selected. I selected the case-study approach 
because it provides the opportunity to more deeply query the roots of this study on 
medication nonadherence and provide an insightful understanding of this concept. Also, 
case studies provide the ability to be exploratory. 
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I formulated four overarching research questions for this study to explain the 
perspectives of HCPs regarding medication nonadherence among African American male 
psychiatric patients using age, gross family income, and marital status as variables. For 
the data collection, I interviewed eligible HCPs who met the study inclusion criteria to 
answer the research questions. Interview Questions 1 through 10 helped answer RQ1, 
whereas Interview Questions 11 through 15 focused on RQ2, RQ3, and RQ4 (see 
Appendix B). 
The research questions crafted to guide this study were: 
RQ1: What are the most important determinants of medication nonadherence 
among African American male psychiatric patients according to HCPs in a 
Chicago-area hospital network? 
RQ2: According to HCPs in a Chicago-area hospital network, how does age 
determine medication nonadherence among African American male 
psychiatric patients? 
RQ3: According to HCPs in a Chicago-area hospital network, how does marital 
status determine medication nonadherence among African American male 
psychiatric patients? 
RQ4: According to HCPs in a Chicago-area hospital network, how does 
socioeconomic status based on gross family income determine medication 
nonadherence among African American male psychiatric patients? 
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Role of the Researcher 
Establishing defined roles for the researcher was vital for this study. As the 
researcher in this study, I had the primary duty of facilitating the study under the 
guidance of my Walden University doctoral committee. As a doctoral student conducting 
this research, I had the goals of upholding honesty, sincerity, accountability, 
transparency, and accuracy at all levels of the study. I was the primary and sole data-
collection agent, guiding ethical consideration for data collection in this study. 
Although I am an HCP, I remained professionally separated from participants in 
this study and fully adhered to the code of conduct and policies established by the 
Institutional Review Board (IRB) of Walden University (see Appendix C). My goal as 
the researcher was to avoid bias, maintain neutrality, and provide a scientific and 
empirical study devoid of biased language. I maintained the credibility of this study 
through various steps to provide a sound and trustworthy empirical study. Also, as the 
researcher, I avoided personal opinions or expectations that could compromise the 
integrity of this study or present situations involving bias. I worked to ensure accuracy, 
precision, truthfulness, honesty, and the execution of scientific research. 
Instrumentation 
The main measurement instrument in this dissertation was one-on-one 
semistructured interviews with HCPs who met the inclusion criteria. The interviews 
aimed to seek responses from HCPs and obtain their viewpoints or perspectives regarding 
age, marital status, and gross family income as factors that influence medication 
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nonadherence among African American male psychiatric patients. Patton (2002) said that 
interviews are useful to capture rich information and meaningful data in qualitative 
research. This is because the researcher obtains the opinion of the participant directly and 
the ability to quote verbatim what the participant is communicating. Thus, I used 
interviews in this study to engage in participant perspectives and viewpoints. 
In contrast to using a questionnaire or survey, semistructured interviews provided 
the avenue to ask open-ended questions and allowed common themes to emerge in the 
data collection through interview discussions. Semistructured interviews allow 
researchers to probe deeply and conduct a flexible and free-flowing conversation 
discussion with the participants. I did not consider group interviews or focus-group 
interviews for this study. I conducted all interviews in person. 
I planned an interview session for this study to last a maximum of 30 minutes. 
Interview sessions were digitally audio-recorded and subsequently transcribed into 
written documents using a voice-to-word digital application. The raw audio-to-text 
conversion application converted the audio files to written documents verbatim. 
Alongside the audio recordings, I also took copious notes of the interview discussions. I 
recorded important points provided by participants in my dedicated notebook. I ensured I 
wrote down as many important points as I could during the interviews. I ensured the 
notes were legible and valuable to the discussion. I later compared the handwritten notes 
to the transcribed notes to ensure the reliability and validity of the data. 
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Psychiatric Healthcare Providers 
Using a qualitative research methodology (semistructured interviews with HCPs), 
I sought to explore the perspectives or viewpoints of HCPs. An HCP is an individual who 
offers preventive, curative, promotional, or rehabilitative health care services (Burgess et 
al., 2017). Hence, the target population for his research was providers who offer services 
to improve the mental health of individuals or treat psychiatric illnesses. Accordingly, 
HCPs in this study were doctors, registered nurses, nurse practitioners, psychiatrists, 
clinical psychologists, clinical social workers, psychiatric mental health nurse 
practitioners, mental health counselors, psychiatric care managers, or clinical social 
workers authorized to offer psychiatric health care, as defined by law (Burgess et al., 
2017). Although the scope and practices of these professionals differed, the identified 
HCPs in these roles all provide health care services to African American psychiatric 
patients. 
Sampling Method and Participant Size 
The purposeful sampling strategy allows researchers to predetermine participant 
criteria and control participant selection (Creswell, 2009). Purposeful sampling enables a 
researcher to set characteristics for the participant population based on defined study 
objectives. As a nonprobability sampling method, purposeful sampling enables a 
researcher to select participants based on the outlined criterion. In using a criterion 
sampling method of purposeful sampling for this study, I used the chosen criteria to 
select HCPs who are experienced in providing health care services to African American 
male psychiatric patients. Among the inclusion criteria are stipulations that study 
46 
 
participants must have had at least 2 years of direct care experience with African 
American male psychiatric patients. Participants must have held a current license. As a 
whole, the inclusion criteria outlined for this study follow: nurses, doctors, psychologists, 
psychiatrists, counselors, or therapists; a minimum of 2 years of direct-care experience; 
experienced working with African American male psychiatric patients; hold a current and 
valid license; and employed in the Chicago-area hospital network of interest. 
Potential participants excluded from this study were people who did not meet the 
inclusion criteria for the study outlined above. These are people who I did not interview 
for data-collection purposes in this study. The exclusion criteria outlined for this study 
follow: HCPs who did not have a minimum of 2 years of experience in the direct care of 
psychiatric patients, HCPs who did not agree to the informed consent, and HCPs who did 
not have direct work experience with African American male psychiatric patients. 
Recruitment Strategy 
To recruit participants for this study, I sent e-mails to known HCPs who are 
colleagues in the healthcare field; I sent these e-mails to colleagues with whom I had 
previously worked. These potential participants also included people I previously met at 
conferences, seminars, networking sessions, professional societies, or former classmates 
who had shared contact information. The recruitment e-mail also asked for referrals to 
eligible participants interested in the study and asked e-mail recipients if they were 
personally willing to participate. I presented the e-mail to potential participants in a 




Subsequently, based on referrals, I employed the snowball approach. I asked 
currently recruited participants to refer me to other people in their professional network 
who might meet the inclusion criteria. Based on referrals, I approached those people with 
the recruitment letter and asked their consent to participate in the study. I was careful to 
prevent undue influence and coercion. I approached the referred HCPs to get their 
consent because individuals may have difficulty saying no to a referral from an authority 
figure. I provide a recruitment strategy e-mail in Appendix D. 
Sampling Strategy and Sample Size Estimation 
Because I could not collect data from everybody or the entire given population, 
Morse (2000) suggested that from five to 50 participant interviews is adequate in a 
qualitative study. For an ethnographic study or a grounded-theory study, Morse (1994) 
suggested a sample size of approximately 30 to 50 participant interviews. However, 
Creswell (1998) suggested 20 to 30 participant interviews is sufficient to achieve 
saturation in similar studies. In phenomenological studies, Creswell (1998) recommended 
five to 25 interviews and Morse (1994) suggested at least six participant interviews. 
These recommendations helped me estimate how many participants I would need; 
however, ultimately, the required number of participants should depend on when 
saturation is reached. 
In case studies, T. Bowen et al. (2010) identified that a minimum of 10 interviews 
should be sufficient to achieve saturation. Based on literature from Morse (2000), I 
estimated a minimum of 30 participant interviews for this study to attain saturation. 
However, I eventually conducted 40 participant interviews to reach saturation. Data 
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saturation occurs when no new or additional responses accrue in the data-collection 
process. Saturation also occurs or when no new themes or codes emerge from the data-
collection process (Baker, Edwards, & Doidge, 2012). I pursued the 40 participant 
interviews to allow myself to continue the participant interview process until no new 
leads or no new themes emerged in the data; at this point, saturation occurred. 
Data-Analysis Tool 
In maintaining data integrity in a qualitative study, Bringer, Johnston, and 
Brackenridge (2006) advised researchers to use computer-assisted qualitative data 
analysis. This form of assistance is useful to condense raw data from multiple sources 
into an applicable single-unit format. With this approach, the computer-assist extracts 
repeating, significant, frequent, and popular themes embedded in the raw data files, 
arranging the data to answer the research questions raised in the study. 
NVivo 11 was suggested as an electronic qualitative data-analysis tool that is 
capable of organizing, exploring, and analyzing the research data easily and quickly. 
NVivo then summarizes and collates the extracted themes to connect the study questions 
and the summary of findings identified from the raw data. This application can provide 
an analysis of thematic and word data in contextual patterns. I used NVivo qualitative 
data-analysis software to perform the data analysis for this dissertation. 
Data Analysis Plan 
Using NVivo 11, based on the data collected during participant interviews, I 
employed an inductive approach to analyze and identify themes about perspectives or 
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viewpoints of HCPs on age, marital status, and gross family income as factors affecting 
medication nonadherence among African American male psychiatric patients. After the 
audio recording of each interview session, I immediately transcribed the recordings to 
written documents. I reviewed each transcribed document multiple times to check for 
errors and accuracy. I read through the transcripts several times to assess content and 
quality. I compared this transcribed note to my handwritten notes to ascertain similarities, 
ensuring I maintained the reliability and validity of the data. In the review, the notes and 
the transcript provided almost an exact match in content. 
Subsequently, the inductive approach for qualitative data analysis commenced. 
With an inductive approach in a qualitative study, researchers condense raw data into a 
succinct format with key themes and common responses extracted in the same pattern 
(Thomas, 2006). This process allowed for the opportunity to detect patterns, similarities, 
and regularities in the generated data. I subsequently explored and analyzed those 
patterns to eventually develop answers to the research questions and reach a conclusion. 
From the collation of the interview transcripts, I established and identified 
meaning units. These are words and paragraphs that are alike and similar or dissimilar in 
meaning. I described the emerging themes from participants’ perspectives or viewpoints, 
verified by the handwritten notes to ensure I represented the overall impression of 
participants in the final data. This was the a priori codebook for the analysis containing 
broad codes and labels assigned to anticipated interview responses, based on the content 
of the interview guide. 
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These a priori codes formed the parent codes derived from the broad themes of 
the generated data. The a priori codebook contained parent codes derived from the broad 
themes of the interview guide and sub codes related to the parent codes. The underlying 
meanings that were considered formed the latent content of the categories that were then 
formulated into themes. The meaning units were then abstracted and labeled with codes 
that provided a better interpretation of a huge chunk of information into small units. 
Patterns and connections among the themes to support or inform the research 
questions were established. Furthermore, I arranged the emerging themes aligned with 
participants’ viewpoints, verified by the handwritten notes to ensure I represented the 
overall impression of participants in the final data accurately. I completed this grouping 
of the raw data based on similarities, synonyms, and differences, to form emerging 
concepts. I employed heading-style coding such that I gathered responses for each 
question into one place for easier analysis. In this process, I separated the themes that 
eventually answered the overarching research questions. This process allowed me to 
group responses to each question into a separate heading. The next step was to organize 
the emerging themes. 
Last, I performed open coding. I uploaded the organized data into NVivo 11 and 
assigned labels from the codebook to portions of the text. I continuously revised and 
updated the codebook with new ideas that were not captured in the initial a priori 
codebook. In certain instances, I assigned more than one label to text segments to 
appropriately capture the ideas expressed by participants. Thereafter, I deduced the major 
emerging themes demonstrated by the essential findings from the research. I described 
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the emerging themes aligned with participants’ perspectives or viewpoints, verified by 
the handwritten notes to ensure I represented the overall impression of participants in the 
final data. 
Ethical Considerations and Issues of Trustworthiness 
In a study setting, researchers typically face ethical and moral challenges from 
concept to designing and reporting that can call the reliability of the study into question. 
Schreier (2012) said that issues regarding, confidentiality, anonymity, informed consent, 
loyalty and allegiance, honesty, and truthfulness, can arise that may compromise the 
quality of a research study. These incidents may bring into question the credibility of 
such studies and comprise the outcome of the study. However, certain key concepts that 
conformed to the system of ethical considerations and trustworthiness in modern research 
principles should be used to gain the trust and credibility of readers. Often, mistakes arise 
from mishaps experienced with studies. Voluntary participation and informed consent are 
the hallmarks of ethical research considerations. These ethical principles require 
participants to be fully informed of why they are involved in the research and the possible 
outcome that can emanate from the results. 
Also, honesty in collecting data, data management, data analysis, and reporting 
study outcomes are crucial for consideration. This qualitative case-study research 
depended markedly on seeking perspectives and viewpoints of respondents; hence, 
honesty and accuracy of participants’ responses and researcher neutrality were crucial to 
maintaining credibility, reliability, and validity of this study. Ensuring that the data 
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collection, data analysis, and study outcomes were conducted without error was quite 
important to assure trustworthiness and reliability. 
Summary 
In Chapter 3, I discussed the research methodology used to execute the present 
research study. Specifically, I presented the study design used and the rationale for 
choosing the indicated study design. The chapter included the research questions that 
needed to be answered by research participants and detailed the related hypotheses. I 
described the data-collection method, the indicated participant-recruitment strategy, and 
the statistical tests used to answer the research questions, and discussed the recruitment 
method and the interview approach for data collection. In Chapters 4 and 5, I provide the 
findings and interpretation of the results. 
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Chapter 4: Results 
I present the results of the data analysis in this chapter. This qualitative case-study 
research was characterized by the exploration of deep meanings and in-depth 
perspectives and viewpoints of HCPs to understand their underlying knowledge regarding 
African American male psychiatric patients in medication nonadherence. This study 
aimed to identify reasons for medication nonadherence using socioeconomic factors 
based on provider viewpoints. The purpose of this study was to explore the perspectives 
or viewpoints of HCPs toward medication nonadherence among African American male 
psychiatric patients using gross family income, marital status, and age as 
sociodemographic factors in a Chicago-area hospital network. 
Research Setting 
The Walden University IRB approved the commencement this study on August 2, 
2019. Recruitment for potential participants started on August 9, 2019, with the 
distribution of recruitment letters through e-mails soliciting prospective participants (see 
Appendix D). I conducted 40 structured interviews with study participants. I used a 
sample structured interview guide during each interview session (see Appendix B). The 
15 interview questions focused on how HCPs perceive medication nonadherence among 
African American male psychiatric patients in a Chicago-area hospital network to help 
answer the four crafted research questions. Interview Questions 1 through 10 helped 




RQ1: What are the most important determinants of medication nonadherence 
among African American male psychiatric patients according to HCPs in a 
Chicago-area hospital network? 
RQ2: According to HCPs in a Chicago-area hospital network, how does age 
determine medication nonadherence among African American male 
psychiatric patients? 
RQ3: According to HCPs in a Chicago-area hospital network, how does marital 
status determine medication nonadherence among African American male 
psychiatric patients? 
RQ4: According to HCPs in a Chicago-area hospital network, how does 
socioeconomic status based on gross family income determine medication 
nonadherence among African American male psychiatric patients? 
This study had a response rate of 30.5% from solicited participants. Of 
participants, 19 responded through initial contacts and 21 responded through the snowball 
approach. I conducted the interviews in locations selected by and conducive to 
participants. The interview sessions took place in private environments to ensure 
confidentiality and anonymity of participant responses. I offered no inducement or 
coercion to prospective participants to influence participation in the study. All 
participants had work experience of at least 2 years with African American male 
psychiatric patients. I excluded eight interested HCPs from participating in the interviews 




I conducted 40 participant interview sessions for this study before achieving 
saturation. Of the participants, 60% were women. The participant pool was diverse in 
experience and of the participants, 75% were highly confident when answering interview 
questions. Study participants included four distinct provider groups: registered nurses, 
nurse practitioners, therapists/counselors, and physicians (see Table 1). 
Table 1 
Profile of Participants 
 n % 
Gender   
Male 16 40 
Females 24 60 
Years of experience as a health care provider 
< 5 years 6 15. 
5–10 years 6 15 
11–20 years 18 45 
> 20 years 10 25 
Years working with African American male psychiatric patients 
< 5 years 4 10 
5–10 years 12 30 
11–20 years 16 40 
> 20 years 8 20 
Health care professional category 
Registered nurses 20 50 
Nurse practitioners 4 10 
Therapist/Counselors 6 15 
Physicians 10 25 
Confidence to answer questions about African American male psychiatric patients 
Highly confident 30 75 
Confident 8 20 
Somewhat confident 2 5 




I sent e-mails to prospective participants using the recruitment letter (see 
Appendix D), seeking their consent to participate in interviews. The recruitment e-mail 
requested volunteers willing to participate in study interview sessions or refer other 
people who might meet the inclusion criteria, using the snowball approach. Interested 
participants responded either by phone or to the e-mail listed in the recruitment letter, 
indicating their willingness to participate in the study. I communicated to all prospective 
participants that the interview would last about 30 minutes. After prospective participants 
agreed to participate, time and venue for interviews were jointly agreed upon. I also 
provided the 15-interview-question document to participants ahead of time to elicit their 
interest and generate thoughts in advance to save time. 
Each interview session started with an overall explanation of the study, as well as 
the background and purpose of the research. I sent informed-consent forms and discussed 
Walden University IRB approval with each participant to establish the credibility and 
scope of the study. After participants provided verbal consent, the actual interviews 
started. I audio recorded all interview sessions and took copious notes. After each 
session, I listened to the recorded voice notes with each respondent to establish the 
accuracy of recordings. I also shared my handwritten notes to ensure accuracy. 
Data Analysis 
Subsequently, I transcribed audio recordings of each interview session to 
Microsoft Word documents. Transcription software converted audio files to Word 
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documents verbatim. I read the transcribed notes several times to ensure no errors existed 
or were incorrectly translated. Subsequently, I saved the transcribed documents on a 
password-protected thumb drive and printed them for review and manual coding. When 
not in use, I made sure all materials were secured under lock. Furthermore, I carried out 
the data-analysis phase in a manner that allowed for reproducibility so subsequent studies 
can apply the same methodology. This was done to confirm the dependability and 
confirmability of the study. 
With the inductive approach for qualitative data analysis, I extracted the essential 
themes and vital information from the raw data to answer the research questions. From 
the collation of interview transcripts, I established and identified meaning units. These 
are words and paragraphs that are alike and similar in meaning. I described emerging 
themes aligned with participants’ perspectives or viewpoints, verified by handwritten 
notes to ensure I represented participants accurately in the final data. These descriptions 
formed the a priori codebook for the analysis, containing broad codes and labels assigned 
to anticipated interview responses based on the content of the interview guide. 
These a priori codes formed the parent codes derived from the broad themes of 
the generated data. The a priori codebook contained parent codes derived from the broad 
themes of the interview guide and subcodes related to the parent codes. The underlying 
meanings formed the latent content of the categories, then formulated into themes. The 
meaning units were then abstracted and labeled with codes that provided a better 
interpretation of a huge chunk of information into small units. 
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Ethical Concerns and Issues of Trustworthiness 
With informed consent obtained from all participants, I made sure to carry out the 
interviews professionally, respectfully, and with no undue influence. I maintained that all 
participants met the inclusion criteria for this study. I excluded prospective participants 
who did not meet the inclusion criteria from participating. All respondents had the 
opportunity to hear and review the interview recordings to ensure I captured their 
responses verbatim and accurately. I also shared my handwritten notes with all 
participants to validate their responses and provide follow-up responses, where needed. 
I ensured consistency and followed the same process for all interview sessions. I 
ensured I asked the same questions in the open-ended format and probed further when 
required. Researchers are to abide by ethical practices and be thorough in their research 
work to gain validity and reliability for their study (Merriam, 1998). I ensured I followed 
proper interviewing skills, did not preempt respondents, and avoided bias to gain truthful 
responses from participants. This research subject is quite sensitive and could be volatile 
if not properly handled; hence, I ensured I presented the questions to respondents in a 
clear, concise, and respectful manner. 
As an HCP myself, I made sure I avoided conflicts of interest as an ethical 
concern. I was very careful not to interject or exhibit body language contrary to 
respondents’ beliefs during the interviews, especially to participants that provided vague 
or outlying opinions. I ensured I communicated with each participant to provide 
responses based on individual experience working with the population of interest. I also 
ensured that I communicated to participants that their responses should be based on the 
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experiences they have had working with the identified group in the Chicago-area hospital 
network. 
Results Presentation 
The conceptual framework used in this study is based on social-cognitive theory. 
The framework examines racial factors relating to medication nonadherence using 
sociodemographic variables. In the analyzed data, I used responses generated from the 
raw data to answer RQ1 (see Table 2). This question targeted understanding the 
perceptions of HCPs regarding the most important determinants of medication 
nonadherence among African American male psychiatric patients according to HCPs in 
the Chicago-area hospital network. 
Table 2 
Frequency Table of Top 10 Keywords/Terms for Research Question 1 
 Word Count 
1 Knowledge/Understanding/Education 119 
2 Side effects 101 
3 Stigma 90 
4 Trust/Fear 81 
5 Quantity/Amount 72 
6 Cost 70 
7 Support system 66 
8 Poison/Chemical 55 
9 Diagnosis 44 




The vast majority of participants agreed that a greater disparity exists for 
medication nonadherence among African American male psychiatric patients than 
members of other racial groups. A consistent response was that provider communication 
and educational level of patients are contributing factors to medication nonadherence in 
this population. The vast majority of respondents noted that the level of education of the 
patient and how the provider communicates the medication regimen to patients usually 
play a part in determining if patients will comply with the medication protocol. 
For example, Participant 12 said, “Inadequate health care provider 
communication and education with patients can cause medication nonadherence,” 
whereas Participant 21 stated, “Patients lack understanding on why they are taking the 
medications. This happens when the purpose and functions of the medications are not 
properly explained to patients.” Participant 4 offered this view: “Providers need to do a 
better job to explain the side effects of medicines, the effectiveness of the medication, 
and safety of the medication to patients in order to establish medication compliance.” 
Additional ideas for HCPs included comments by Participant 32—"Medication 
information materials are written in way to high literacy level for psychiatric patients and 
this fails to educate the patients leading to medication non adherence.” and Participant 1: 
“Sometimes psychiatric patients engage in medication non adherence because the 
prescribed medication might interfere with lifestyle or requires significant behavioral 
changes that the patients is not willing to embrace.” 
Another reason elucidated about medication nonadherence of African American 
male psychiatric patients was the complexity of the medication and the associated stigma. 
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In that regard, Participant 8 said, “Patients that requires high drug regimen are usually 
more prone to non-adherence and not able to take their medication as prescribed e.g. 
number of pills or doses per day.” Participant 22 suggested “Stigma associated with 
taking psychiatric medicines for an extended period over time induces medication non 
adherence.” Finally, Participant 9 averred, “Intentional medication non adherence is high 
among African American patients because of lack of information resources as well as 
limited health literacy.” 
Another consistent response from participants was that patients sometimes exhibit 
fear, which prevents them from being compliant with their medication, and this factor 
also aligns with lack of education and information on the patient treatment plan. The fear 
of medication compliance or an extended period of time of taking medications occurs 
when patients do not agree with the diagnosis or when the patient’s mental status impacts 
how they view the medication. Participant 10 said, “Some African American male 
patients believe that some medication such as Psychiatric medication causes impotence 
and such medications are harmful.” Participant 22 suggested, “The fear of being labeled 
as a psychiatric patient increases medication non adherence within African American 
psychiatric male patients.” In agreement, Participant 30 opined, “The fear of huge 
medication cost is a reason why African American psychiatric male patients do not use 
their medication.” Finally, Participant 1 also addressed fear: “Patients fear the absence of 
confidentiality or privacy and that is why they don’t use their medication.” 
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Participant 10 raised specific points on cultural and social factors relating to 
African American male psychiatric patients. This participant noted that the social and 
cultural background of patients in this population induces medication nonadherence: 
A typical African American Psychiatric male patients believes they will 
automatically be mistreated by the health care system so they are prone to 
medication nonadherence. … The suspicion and bias of the health care system 
towards African American patients causes them to go through medication non 
adherence. (Participant 10) 
RQ2 sought to investigate how HCPs in the Chicago-area hospital network view 
and understand age to determine medication nonadherence among African American 
male psychiatric patients. In evaluating this question, HCPs perceived that age did not 
individually play a part in determining medication nonadherence in patients as a 
determinant factor. Rather, difficulty with medication adherence is common to all age 
groups. However, older adults may have more difficulty adhering to their prescription 
plan (Black, Rabins, German, McGuire, & Roca, 1997). A larger portion of study 
participants determined that younger patents are more likely to comply with their 
medication plan than older patients in this population. Of participants, 55% mentioned 
that younger African American male psychiatric patients are more adherent, whereas 
45% agreed that older African American male psychiatric patients are more adherent. 
Study participants noted that older African American male psychiatric patients have 
increased levels of experience in managing their medication regimen and are less likely 
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to be nonadherent. Study findings noted that older African American male psychiatric 
patients are more medication adherent. 
Study results also showed that older patients are more likely not to consume their 
prescribed medication compared to younger patients, based on provider 
recommendations. Rather than forgetting to take medications, study results also showed 
that when older patients do not comply with their prescribed medication plan, providers 
attribute that lack of compliance with an inability to renew their prescriptions with good 
timing and in some cases procrastinating to refill prescription. HCPs perceived that older 
patients living in a home setting have more support, encouraging them to be more 
adherent compared to younger patients residing alone. This may explain why older 
patients may be less likely to be nonadherent compared to younger patients (see Table 3). 
Table 3 
Age as a Determinant of Medication Nonadherence 
 n % 
Younger African American male psych patients are more non adherent 18 45 
Older African American male psych patients are less non adherent 22 55 
Note. N = 40 
Participant 22 indicated, “Younger ages are more medication adherent compared 
to older ages because of ignorance and lack of information.” Participant 30 expressed, 
“Based on my experience the older patients are usually the ones that exhibit medication 
nonadherence, they have strong potential risk factors for medication nonadherence.” 
Participant 40 expressed the same notion, “Older Patients over 60 years of age typically 
are less non adherent and younger patients are the more nonadherent.” Finally, 
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Participant 18 said, “Typically, older patients consume several medication types because 
of multiple diseases and health conditions, so they are sometimes known to be less non 
adherent because they need all the medication for their continued living.” 
RQ3 sought to investigate how HCPs in a Chicago-area hospital network 
understand how marital status determines medication nonadherence among African 
American male psychiatric patients. In answering RQ3, the majority of respondents 
agreed that marital status significantly and independently aligned with medication 
nonadherence in African American male psychiatric patients in that the level of 
medication nonadherence is lower in married patients. Analysis of respondent feedback 
on this research question showed that lower nonadherence is common among patients 
who are married or cohabitated with a significant partner and lived together in a home 
setting. Of participants, 80% mentioned that the presence of a significant partner serving 
as a support system induces married patients to be more medication adherent. Study 
results indicated a high level of medication adherence among patients who are married, as 
the relationship support system acts as positive reinforcement and emotional 
encouragement, thereby reducing medication nonadherence. Married patients enjoy 
support, attention, and care from their partners, which helps reduce the level of 
medications nonadherence. 
HCPs reported that encouraged health care use commonly leads to less 
nonadherence by patients who are emotionally engaged. Several participants repeatedly 
mentioned that married patients are more likely to follow their medication regimen. Of 
study respondents, 20% reported that a higher prevalence of medication nonadherence 
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occurred with patients who lacked emotional support compared to patients who are 
married or have other forms of emotional support. Several reasons evolved from the 
study analysis. In sum, participants noted that home-domiciled patients, particularly 
married patients, showed higher levels of medication adherence (see Table 4). 
Table 4 
Marital Status as a Determinant of Medication Nonadherence 
 n % 
Married African American male psych patients are less non adherent 32 80 
Unmarried African American male psych patients are more non adherent 8 20 
Note. N = 40 
Married patients are more likely to follow their medication regimen. (Participants 
4, 21, 18, 23, and 36). For example, Participant 2 said, “Significant others or partners 
influence medication compliance.” Specially, Participant 33 indicated, “Married patients 
enjoy the support, attention, and care from their lovers which helps to reduce the level of 
medications nonadherence. … The level of medication nonadherence is lower in married 
patients and have lesser health risk.” Participant 14 also thought “Married patients will 
have someone to remind them to take their prescription medication compared to 
unmarried patients.” 
However, three participants provided contrary perspectives on this topic, asserting 
that marital status might not influence medication adherence. Participants 2, 4, and 30 
noted that marital status might not directly influence medication nonadherence in this 
group of patients. These participants mentioned that marriage in its entirety cannot be the 
sole independent parameter to determine medication adherence. For instance, Participant 
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2 said, “Some psych meds cause sexual nonperformance, so certain patients hide their 
prescribed medication from their partners.” In line with that notion, Participant 4 
indicated, “Marital status do not really play any role in medication non adherence in 
African American patient because some are not even married and liv alone.” Participant 
30 emphasized, “Marital status play little to no role in determining direct correlation with 
medication non adherence.” 
It was evident that medication nonadherence is a complex behavioral issue with 
several health consequences. Therefore RQ4 sought to understand how HCPs in a 
Chicago-area hospital network understand socioeconomic status, based on gross family 
income, to determine medication nonadherence among African American male 
psychiatric patients. Patients’ knowledge and beliefs about their health conditions has 
been identified as either a motivation or barrier to medication adherence (WHO, 2003). 
Responses to this question were widely divided among participants (see Table 5). 
Table 5 
Family Income as a Determinant of Medication Nonadherence 
 n % 
Younger African American male psych patients are more non adherent 16 40 
Older African American male psych patients are less non adherent 16 40 
No opinion on how family income affects medication non adherence 8 20 
Note. N = 40. 
HCPs identified several variables and factors to determine medication 
nonadherence among African American male psychiatric patients. HCPs identified no 
single factor that independently causes this behavioral issue. Amid the array of responses 
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received for this question, a common line for many respondents was that a patient’s 
cognitive ability to self-manage their prescription-medication protocol is vital and 
important to reducing medication nonadherence. Therefore, the level of health literacy of 
the patient is a key indicator of medication adherence. Low health literacy and limited 
education proficiency were identified as factors that influence medication nonadherence. 
In addition, limited access to health care facilities and the availability of the prescription 
medication were also identified as determinant factors. Characterized by a patient’s 
inability to access a pharmacy, high medication costs, the lack of or inadequate insurance, 
or variations in the severity of symptoms arose across patient profiles. 
In the course of this study, factors that create medication nonadherence can 
change from time to time among patients and a combination of variables with multiple 
risk factors can cause nonadherence. Participants noted that medication nonadherence can 
be viewed through the lens of unintentional or intentional. HCPs described unintentional 
medication adherence to be simply the patient forgetting to use the medication without 
real cause; in contrast, intentional medication nonadherence mainly aligned with patient 
refusal to comply with the prescription protocol. 
Participants identified gross family income as a factor that induces medication 
adherence but was not a major factor because patients with this diagnosis would be able 
to access government-funded programs and free benefits. The key information to answer 
this question was not the availability of drugs but the ability of the patient to facilitate the 
use of the medication. Patient access to medicines is one issue and resources necessary 
for medication compliance is another. Participant 4 offered, “Family income contributes 
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to medication non adherence, low income family will likely cannot afford the 
medication.” Participant 30 said, “Patients from low income family will likely to practice 
medication nonadherence because they cannot afford the cost of the medication.” Finally, 
Participant 8 suggested, “Most African American psychiatric patients do not have good 
health care coverage or insurance.” 
Summary 
In this chapter, I presented the study finding based on respondent participation in 
interviews to answer the four research questions. Some results confirmed factors 
previously established in the literature, whereas other results elucidated points not 
inherently observed in the previous review of literature. New findings, based on 
respondent feedback, also emerged. The next chapter provides an in-depth explanation 
and discussion of the results. Chapter 5 details discussion of the research questions, the 
implications for positive social change, and recommendations for future studies. 
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Chapter 5: Discussion, Conclusions, and Recommendations 
The purpose of this qualitative case study was to explore the perspectives or 
viewpoints of HCPs toward medication nonadherence among African American male 
psychiatric patients using gross family income, marital status, and age as 
sociodemographic factors in a Chicago-area hospital network. As established in literature, 
medication nonadherence—when patients do not take their prescribed medication as 
directed—is a clear hindrance to favorable health outcomes. Results of nonadherence 
may have severe consequences for patients with chronic conditions such as psychiatric 
disorders. Nonadherence ultimately underscores increasing issues of medical cost and 
patients’ disease progression. Whether nonadherence is intentional or unintentional, this 
behavioral issue is a predictor of poor or diminished health outcomes, especially when a 
racial group or geographic entity is individually investigated. 
This study was undertaken to explain HCPs’ perceptions of medication 
nonadherence among African American male psychiatric patients. Understanding 
provider perceptions of the stigma involving psychiatric patients helps ameliorate this 
retributive medical condition. Because HCPs are major participants in providing quality 
care to patients, their opinions, attitudes, and perceptions can influence the quality and 
quantity of care they make available to patients (Henker et al., 2018). Furthermore, 
impressions of caregivers regarding patients influences clinical outcomes in a positive 
healthcare environment. Findings from this study evolved through interviews with 40 
HCPs in a Chicago-area hospital network who met the inclusion criteria. 
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Interpretation of the Findings 
HCPs interviewed for this study were nurses, nurse practitioners, 
counselors/therapists, and physicians from a Chicago-area hospital network. Respondents 
to this study noted that the subject of psychiatric medical conditions, coupled with the 
uniqueness of African American male patients, makes this research an interesting topic. 
Copeland (2005) said that disparities already exist in healthcare outcomes for African 
Americans due to historical practices or polices and societal perceptions. In addition, 
African American patients hold more health risk factors than other racial groups. Hence, 
medication nonadherence is one of the barriers that affects effective healthcare delivery 
to this racial group. 
Psychiatric Patients and Medication Nonadherence 
Like all cases of medication nonadherence, the stigma associated with psychiatric 
medical conditions complicates patients’ ability to follow prescription protocols. 
Respondents noted HCPs have negative views of patients who suffer from psychiatric 
conditions. This stigma, according to study participants, leads to internalized shame about 
having this condition, causing some patients to ignore the diagnosis and engage in 
intentional medication nonadherence. Furthermore, negative beliefs, myths, and 
erroneous assumptions about patients who suffer from conditions that require psychiatric 
care induce patient shame, thereby leading to medication nonadherence. Due to stigma, 
perceived shame, and negative beliefs, historically, some patients have been unable to 
fully embrace their treatment directives, leading to medication nonadherence. For 
example, Participant 21 said, “Most people believe that patients with psychiatric 
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disorders are socially backward, violent, or could be dangerous, that’s why most patients 
do not admit their diagnosis and fail to use their medication.” Aligned with that notion, 
Participant 18 said, “Usually social stigma traps psychiatric patients and they will refuse 
to be compliant with their treatment plan.” Participant also suggested, “ Social stigma and 
discrimination usually make psychiatric patients to engage in medication nonadherence.” 
Finally, Participant 26 opined, “Stigma usually make psychiatric patients to be reluctant 
to ask for help or to get the necessary treatment they require.” 
In further discussing psychiatric patients, Lacro et al. (2002) noted that HCPs’ 
perceptions are necessary because whether unintentional or subtle, negative views or 
stereotypes can hinder patient–provider relationships, often leading to medication 
nonadherence. Stigma leads to discrimination, and discrimination negatively impacts 
healthcare delivery; hence, HCPs’ perceptions need to be positive to prevent deterioration 
of patient conditions. Respondents in this study said that increasing efforts to eradicate 
stigma and eliminate myths involving psychiatric conditions are plausible means to 
prevent medication nonadherence in this population. As an example, Participant 4 
averred, “Although the stigma abounds for psychiatric patients it can be eradicated with 
intensified education, awareness, and strong support system.” Participant 40 though 
“Health care workers should not judge, label, or discriminate patients. Providers should 
treat all patients with respect, dignity and honor irrespective of their medical condition,” 
and Participant 2 said, “ Health care workers need consistent education, training, and 
support to help manage the existing bias towards psychiatric patents. 
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Uniqueness of African American Male Psychiatric Patients 
Psychiatric patients typically are able to manage their condition, recover fully, or 
lead normal lives if they get help and avoid medication nonadherence (Hyre, Krousel-
Wood, Muntner, Kawasaki, & DeSalvo, 2007). Therefore, although African American 
male psychiatric patients may be challenged to adhere to medication regimens, their 
ability to normalize medication adherence is achievable if properly executed. HCPs who 
served these groups identified that African American patients, more than members of 
other racial groups, are more likely to miss medication or fail to comply with their 
treatment plan, based on socioeconomic factors. Health disparities affect African 
American male patients particularly and impede positive health outcomes. Respondents 
noted that cultural influences, perceived discrimination, and limited knowledge of their 
medical condition contribute to medication nonadherence in this African American male 
psychiatric patient population. 
Study findings also showed that members of the African American community 
lack detailed information and misunderstand psychiatric conditions. In African American 
communities in the United States, patients with pronounced psychiatric conditions tend to 
have difficulties securing or holding a job, holding steady and long-term emotional 
relationships, and being socially inclusive. Patients in this population may be evasive 
about their diagnoses and refuse prescribed medication regimens. Study findings showed 
that African American society in general has stigmatized psychiatric conditions, as 
identified in responses answering Research Question 1. For instance, “Many Black 
patients do not fully understand what psychiatric conditions are and avoid talking about 
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it” (Participant 32) and “African American psychiatric patients have the misconception 
that psychiatric conditions are personal weakness” (Participant 36). 
African American patients often seek spiritual activity rather than medical 
interventions to combat psychiatric conditions as alternative solutions. R. J. Taylor and 
Chatters (1991) reported that 85% of African Americans in the United States identify 
themselves as somewhat religious and use prayer as one coping mechanism in medical 
situations. Reliance on religion often hinders patients from seeking orthodox medicine, 
especially for psychiatric disorders. In 2001, the Office of the Surgeon General 
publicized that reliance on spiritual interventions sometimes leads to downplaying 
psychiatric conditions among African American male patients as a way to preserve 
personal ego. Participant 1 agree, “Some African American psychiatric patients use 
religion to respond to their condition and engage in medication adherence.” Participant 
10 explained, “There is the myth that psychiatric disorders are an affliction and a 
punishment of precious wrong deeds from God.” and Participant 6 commented, “Some 
African American patients prefer to seek help from religious institutions while they 
practice intentional medication nonadherence.” Participant 10 also thought, “Spiritual 
practices are a strong part of treatment plan for African American patients.” 
Respondents in this study mentioned that provider bias, intentional or 
unintentional, also play a role in medication nonadherence for African American male 
patients. Respondents noted that this bias is rooted in cultural competence, leading to 
poor health outcomes. Cultural misgivings cause mistrust in stratified healthcare facilities 
providing healthcare services to patients , and also induce medication nonadherence. 
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Inadequate provider communication and education with African American male 
psychiatric patients can also lead to medication nonadherence because patients lack 
necessary information regarding the side effects of medicines, the effectiveness of 
medications, and the safety of medications. Patients may have incorrect perceptions of 
medications. Psychiatric patients may lack the necessary understanding of why they are 
taking the medications, further exacerbated when HCPs do not properly explain the 
purpose and functions of the medications to patients. Furthermore, psychiatric patients 
who requires high drug regimens are usually more prone to nonadherence and unable to 
take their medications as prescribed, due to inadequately communication. 
Socioeconomic Factors and Medication Nonadherence 
Psychiatric conditions do not discriminate based on race, gender, or 
socioeconomic factors. Anyone can experience the challenges of psychiatric illness, 
irrespective of their background. However, this study’s findings confirmed that 
socioeconomic factors are indeed determinants of medication nonadherence in African 
American male psychiatric patients. 
Based on gross family income and on an aggregate level for all U.S. families, 
African American families are relatively poor (Office of the Surgeon General, 2001). In 
their report, the Office of the Surgeon General further stated that 22% of African 
American families reported family incomes below the poverty line compared to other 
racial groups. Furthermore, mental health conditions are likely associated with those who 
live around poverty than those with broader income spectrums. Although poverty rates 
continue to shrink as the years progress, the distribution of wealth grows more complex 
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and diversified. As family income becomes a vital socioeconomic factor, family income 
should not be a strong determinant of access to medication and adherence. 
On average, 30% of African Americans with mental illness seek medical help, 
compared to the U.S. average of 43% (D. R. Williams & Williams-Morris, 2000). Hence, 
rather than use income as a solid block in explaining mediation nonadherence, the ability 
to access health care services seems more prevalent in the African American population. 
Participant 4 concurred: “Family income contributes to medication nonadherence because 
low income family will likely not be able to afford the cost of medication” and 
Participant 30 thought, “Patients with psychiatric disorders should be able to access 
government funded programs and benefits.” 
Patients who are married are more likely to avoid medication nonadherence 
because they have family support that encourages and supports medication compliance. A 
married patient or one cohabiting with a partner is likely to be more medication 
compliant compared to patients living alone. A possible explanation is that married 
patients have significant partners who encourage them to use their medication and help 
them remember, in the case of unintentional medication nonadherence. Patients living 
alone are at greater risk of medication nonadherence. Study findings to answer this 
research question suggested that although marital status was not a significant individual 
predictor of medication nonadherence, unmarried African American male psychiatric 
patients were more likely to be medication nonadherent. For example, Participant 33 said, 
“The level of medication nonadherence is lower in married patients.” Put another way, 
Participant 30 indicated, “Relationship status of patients has an effect in mediating 
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medication nonadherence.” Finally, Participant 14 agreed that “Married patients will have 
someone to remind them to take their prescription medication compared to unmarried 
patients.” 
In this study, I discovered that difficulty with medication adherence is common to 
all age groups and can happen to anyone. However, older adults may have more difficulty 
adhering to their prescription plan. Black et al. (1997) identified that 58% of older 
African America patients with mental disorders do not receive care and are prone to 
medication nonadherence. This is because members of the aging population (aged ≥ 65 
years) often take more than one prescription medication, thereby finding it challenging to 
keep up, which can lead to medication nonadherence. In particular, 40% of older adults 
take five or more prescription drugs per day (Black et al., 1997). 
In the older generations, factors such as lower cognitive function, memory loss, 
multiple health conditions, and medical history could cumulatively induce medication 
nonadherence. Members of older generations are more encumbered with issues of life, 
finances, shelter, and food, and may be less compliant in pursing medications. Study 
findings showed that although age is not an independent determinant of medication 
nonadherence on African American male psychiatric patients, older adults who take 
multiple medications are more likely to indulge in medication nonadherence. By way of 
example, Participant 1 said, “Older patients are more likely to use their prescription 
medication if it has easy dosing schedule but more likely to comply if it involves 
complex dosing schedule.” Participant 12 also thought “Older patients have problems 
with dosing frequency and refilling their prescription promptly.” Participant 19 observed 
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that “Older patients are always afraid of adverse effect of the drugs and they have a fear 
for using the medication.” In contrast, Participant 35 said, “I don’t think age plays a part 
in determine medication nonadherence in African American male psychiatric patients.” 
Key Findings 
Based on responses received during study interviews, participants agreed that 
medication nonadherence is a national epidemic in the African American community that 
contributes to poor health outcomes. Participants’ responses showed that, indeed, 
socioeconomic factors induce how patients fare in relation to medication compliance. A 
summary of key findings for this study follows: Intentional medication nonadherence is 
prevalent among African American psychiatric patients because of their lack of 
information resources and limited health literacy/education. The lack of effective and in-
depth communication methods between psychiatric patients and HCPs influences 
medication nonadherence in this population.  Patients who require high drug regimens are 
more prone to medication nonadherence and unable to take their medication as 
prescribed. African American patients hold cultural and historical perceptions of 
psychiatric disorders, types drugs/medicines, and overall treatment options that are not 
rooted in science. The stigma associated with using psychiatric medications for an 
extended period of time induces medication nonadherence. Cultural competence for 
HCPs is important in treating African American male psychiatric patients, with a need to 
adapt to this racial reality to ensure favorable health outcomes. Sometimes health care 
workers face weak capacity of the healthcare system to properly educate African 
American patients and provide the necessary treatment. Medication nonadherence does 
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not appear to be solely influenced by a single socioeconomic factor. A magnitude of 
variables can serve as determinants of medication nonadherence, based on the uniqueness 
of the race of patients. Health care workers’ perceptions need to be positive about 
psychiatric patients to prevent difficulties in providing care. 
Limitations of the Study 
This study was limited to describing participants’ perceptions of medication 
nonadherence in African American male psychiatric patients in a Chicago-area hospital 
network; that is, I only sampled respondents from caregiving institutions in a Chicago-
area hospital network. Another limitation is the uneven participant ratio based on job 
function. In the 40-participant pool, the ratio of nurses to nurse practitioners to counselors 
and physicians was not evenly distributed. However, for this study, this variation did not 
present any limitation in their experience and competence to answer the interview 
questions. 
As the interviewer, my experience as a caregiver to the target population 
empowered study respondents to openly and truthfully answer the interview questions. In 
addition, this study was limited to responses provided, aligned with participants’ 
perceptions. Respondents provided their perceptions based on their job experience with 
African American male psychiatric patients, working in Chicago-area hospitals. 
However, some participants provided responses based on their entire work experience 
outside of the Chicago-area hospital network, including previous job locations. This 
might be considered a limitation. However, because participants answered the interview 
questions truthfully, based on their perceptions and not generally restricted to any 
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particular geographical area, the limitation is insignificant. Overall, as the researcher, I 
believe that all participants answered the interview questions truthfully and to the best of 
their knowledge, based on meeting the study inclusion criteria. 
Recommendations 
This study investigated the perceptions of HCPs about African American male 
psychiatric patients. I recommend further studies investigate the same perceptions about 
African American female psychiatric patients. Some variations may arise in how health 
workers perceive male patients compared to female patients. Researchers answering this 
recommendation will aid in understanding how HCPs perceive African Americans in 
general (men and women). Second, I recommend moving this study to another 
geographical area and using a broader geographic spectrum of participants. Opening the 
study concept to a national scope might elicit information particular to members of the 
African American race, particularly for psychiatric patients. 
Furthermore, a study that compares psychiatric disorders to other chronic medical 
conditions might be plausible. Such a study could uncover if similar chronic medical 
conditions are determinants of medication nonadherence in the same capacity for African 
American patients. For example, a study comparing those with diabetes, ulcers, or cancer 
to those with psychiatric disorders might aid in understanding how patients who indulge 




This study evaluated the perceptions of HCPs on African American male 
psychiatric patients regarding medication nonadherence. Findings from this study 
confirmed that disparities exist in health delivery to African American male psychiatric 
patents and immediate solutions are required to improve services to this group. The 
findings answered how and why health caregivers perceive African American male 
psychiatric patients to be medication nonadherent. Providers’ perceptions are essential to 
offering caring and compassionate care and this manner of care can influence medication 
compliance. The first implication for social change is that this study identified that 
healthcare workers have a vital need to develop and intensify educational and informative 
programs to align with the specific needs of African American male psychiatric patients. 
Providers need to understand how to specifically cater to this group, based on identified 
factors that make African American male psychiatric patients different. 
Providers need to enhance real-time communication and education not only with 
patients, but with society at large, aiming to eradicate stigma and unfounded myths 
regarding psychiatric disorders. The use of technological applications for patients to 
manage their medications can be promoted to improve unintentional medication 
nonadherence. Also, reward and appreciation systems would encourage patients to follow 
their medication directions. A reward system can provide motivation for patients to use 




The purpose of this qualitative case study was to explore the perspectives or 
viewpoints of HCPs involving medication nonadherence among African American male 
psychiatric patients using gross family income, marital status, and age as 
sociodemographic factors in a Chicago-area hospital network. The results of this study 
described providers’ viewpoints on medication nonadherence and their influence on 
effective healthcare outcomes for African American male psychiatric patients. This study 
emphasized the need for providers to cater to African American patients due to the 
inherent risk factors particular to this race. Although medication nonadherence was 
observed to be higher among African American male psychiatric patients compared to 
other patients, medication nonadherence does not appear to be solely influenced by one 
socioeconomic factor; a magnitude of variables can serve as determinants of medication 
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Appendix A: Interview Questions 
Date: ____________________________________________________ 
Location: _________________________________________________ 
Name of Interviewer: ________________________________________ 
Interview # _______________________________________________ 
1. How many years have you been a Health Care Provider? 
2. How many years have you been a Health Care Provider to African American 
Psychiatric male patients? 
3. Participant gender: _______ Female _____ Male. 
4. What category of Health Care Provider are you? 
5. How confident are you to answer questions concerning African American 
Psychiatric male patients? 
6. What in your opinion are some of the causes for medication non adherence in 
African American Psychiatric male patients? 
7. Can you describe any barriers that you have encountered when dealing with 
African American Psychiatric male patients? 
8. Why do you feel African American Psychiatric male patients engage in 
medication non adherence? 
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9. What are your guidelines for categorizing a patient as non-complaint to 
medication? 
10. How do you encourage African American Psychiatric male patients to be 
medication compliant? 
11. What are the perceptions of health care providers to age as a determinants of 
Medication Adherence among Psychiatric African American Male Patients? 
12. What are the perceptions of health care providers to marital status as a 
determinants of Medication Adherence among Psychiatric African American Male 
Patients? 
13. What are the perceptions of health care providers to gross family income as a 
determinants of Medication Adherence among Psychiatric African American Male 
Patients? 
14. Do you think HCPs have enough training and knowledge to adequately care for 
African American Psychiatric male patients? 
15. Is there anything else you feel you would like to say that will help me understand 
the subject of medication non adherence in African American Psychiatric male patients? 
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Appendix B: Interview Protocol 
All interviews were in person semi-formal discussions. All interviews were audio 
recorded 
1. The study proposal was discussed with each prospective participant 
2.  The informed consent process was shared with each prospective participants 
and a verbal consent is made from prospective participants to commence he 
interviews 
3. I also informed each participant that I am only interested in an honest 
feedback and learning about their true experiences working with the target 
population 
4. At this stage, I asked if the participants had any questions or concerns before 
we commenced each interview. 
5. I started the interview session and ensured to take the audio recording of the 
entire conversation with each participant. 
6. At the conclusion of the interview, I reviewed the recordings with each 
participant alongside my hand written notes. 
7. I asked the respondents for referrals to suggest the names of other potential 
participants in their professional circle that may also be interested in the study, 




8. At this staged, I thanked the participants for their time and effort to participate 
9. I stopped the interview and communicated the next steps in the process to the 
participants 
10. I will ended the audio recording at this time 
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Appendix D: Recruitment E-mail 
Please Share Your Expertise as a health care Provider for African American 
Psychiatric male patients’ medication non adherence. I am Felix Agoye and I am a 
doctoral candidate at Walden University. I am in the process of seeking participants to 
volunteer in a doctoral research study. The purpose of this research is to explore 
perspectives of health care providers to Medication Nonadherence among Psychiatric 
African American Male Patients within the Chicago area hospital network. 
I am cognizant of the fact that your time is valuable to you and I appreciate your 
consideration to engage in this study. To get your opinion for this study, we need to meet 
for a brief interview of approximately 30 (thirty) minutes. This interview will be at a time 
that is most convenient for you. The interview can be held at a location of your choice in 
private and without interruptions. The meeting can also be done by phone/video 
conferencing (Skype) considering your flexibility. The interview meeting is designed to 
simply get more information about your experience as a health care provider treating 
African American male psychiatric patients. Participation is voluntary and all information 
will be kept strictly confidential. Also you would be anonymous and no information 
about you would be included in the study report. If you are willing to participate in 
interview meeting, please contact me by phone at xxx to schedule an interview time that 





Doctoral Candidate Walden University 
